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Abstract
Oxidative exposure of cells occurs naturally and may be associated with cellular damage and dysfunction. Protracted low
level oxidative exposure can induce accumulated cell disruption, affecting multiple cellular functions. Accumulated
oxidative exposure has also been proposed as one of the potential hallmarks of the physiological/pathophysiological aging
process. We investigated the multifactorial effects of long-term minimal peroxide exposure upon SH-SY5Y neural cells to
understand how they respond to the continued presence of oxidative stressors. We show that minimal protracted oxidative
stresses induce complex molecular and physiological alterations in cell functionality. Upon chronic exposure to minimal
doses of hydrogen peroxide, SH-SY5Y cells displayed a multifactorial response to the stressor. To fully appreciate the
peroxide-mediated cellular effects, we assessed these adaptive effects at the genomic, proteomic and cellular signal
processing level. Combined analyses of these multiple levels of investigation revealed a complex cellular adaptive response
to the protracted peroxide exposure. This adaptive response involved changes in cytoskeletal structure, energy metabolic
shifts towards glycolysis and selective alterations in transmembrane receptor activity. Our analyses of the global responses
to chronic stressor exposure, at multiple biological levels, revealed a viable neural phenotype in-part reminiscent of aged or
damaged neural tissue. Our paradigm indicates how cellular physiology can subtly change in different contexts and
potentially aid the appreciation of stress response adaptations.
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Introduction
Cellular adaptations to environmental changes are likely to be
highly complex and involve many of the basic cellular functions. It
is crucial for cellular/organismal homeostasis during lifespan that
molecular systems can adapt and retain functionality despite long-
term variation of environment. Aging is a complex multifactorial
process, unique in its exact etiology to each individual. There are
however several key factors common amongst current hypotheses
of aging, one of them being accumulated oxidative stresses. The
Harman free radical/oxidative stress theory of aging underpins
one of the most popular concepts regarding the biochemical/
molecular factors in aging [1]. Harman proposed that physiolog-
ical iron and other metals would cause reactive oxygen species
(ROS) to form in cells as a by-product of normal redox reactions.
ROS are a by-product of a variety of pathways in aerobic
metabolism. The mitochondrial electron transport chain accounts
for the majority of the total oxygen metabolized by the cell, and
the by-products produced by the electron transport chain (e.g.,
superoxide anion radicals, hydrogen peroxide, and hydroxyl
radicals) are potential sources of oxidative damage to the
mitochondrion itself and other cellular compartments. Endoge-
nous ROS-scavenging pathways represent an antioxidant defense
system, including both small molecules (tocopherols, vitamin C,
glutathione, etc.) and antioxidant enzymes (the superoxide
dismutases (SOD), the glutathione peroxidases, catalase). The
balance between these pathways determines the absolute level of
oxidative stress. In aging, complex accumulated systemic imbal-
ances may result in the generation of excess free radicals that
overwhelm cellular antioxidant defenses, thereby causing oxidative
stress [2]. Aging has also been associated with both a disruption of
mitochondrial function [3] along with the steady increase in ROS
species, a state that may seem paradoxical as the mitochondria
may be the prime source of the ROS. Therefore, it is likely that
there are complex interactions between the ROS generating and
buffering systems in the aging process. Studies have shown an age-
related increase in oxidative damage to a variety of molecules,
lipid, protein or DNA, in multiple organisms [4–6]. Age-
dependent oxidative damage has been implicated in the pathology
of age-related disorders in multiple organ systems, e.g. sporadic and
familial Alzheimer’s disease, Huntington’s and Parkinson’s disease,
amyotrophic lateral sclerosis, cardiovascular disease, Type II
diabetes and cancer [7–12]. Experimental excessive ROS stress
can trigger cellular senescence in multiple human cell lines
[13,14]. After exposure to high concentrations of hydrogen
peroxide (0.2–1 M) human cells undergo premature senescence,
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significant changes in gene expression [15,16]. Metabolic
inhibitors, e.g. oligomycin or antimycin A, also induce ROS
production and induce cellular senescence, demonstrating that
defective mitochondria are involved in oxidative cellular senes-
cence [17]. High concentration (0.25 M), acute (90 minute)
peroxide exposure has also been shown to switch energy
generation in human cells from aerobic metabolism to glycolysis.
This functional energetic shift appears to be an important
hallmark of aged tissues in numerous species, as proposed by the
epigenetic oxidative redox shift theory of aging [18–21]. The
disruption of energy regulation therefore may be a hallmark of
aging and neurodegeneration [22–24] however, the specific
molecular connections between these two events still remain to
be comprehensively identified. From a therapeutic point of view,
interventions ameliorating aging/neurodegeneration-related pa-
thologies have therefore been targeted to modulating anti-oxidant
mechanisms as well as inflammatory processes, DNA repair
mechanisms and modulation of neurotrophic receptor systems
[25–28]. Disruption of the neurotrophin brain-derived neuro-
trophic factor (BDNF) activity has been associated with aging and
multiple neurodegenerative diseases that demonstrate oxidative
pathological aspects [29–35]. It has also been shown that many
other profound deficits in other receptor systems, e.g. cholinergic,
serotoninergic, dopaminergic, histaminic, are also implicated in
aging and neurodegeneration processes [36–39].
Cell death and atrophy have been strongly associated with the
aging process and neurological disorders, however in some cases
cognitive impairment and aging may occur without this pro-
nounced tissue pathology. Therefore in these cases one could
hypothesize that the exposure of cells to non-lethal oxidative
stresses for a considerable period of time may be associated with
aging [40]. This facet of oxidative stress-induced pathophysiology
is the crux of this study. We have employed minimal levels of
oxidative stress to mimic the low level of consistent stress
potentially experienced by cells aging normally or in the early
stages of neurodegenerative disorders. Our decision to focus on the
most minimal levels is aimed at trying to improve our knowledge
of the earliest effects of oxidative insults. We feel that it is
important to fully comprehend the cellular adaptive responses
during the early effects of oxidative insults, as it is likely that
therapeutics will be most efficacious at this time (i.e. before
widespread neuronal cell death). We show that neural cells
respond strongly to even minimal oxidative stresses in a manner
that affects energy metabolism, calcium regulation, tyrosine kinase
activity and receptor-mediated responses and protein expression
that in-part mimics that of aged/damaged neuronal tissue.
Therefore, this model may be a useful tool for investigating the
development of novel pharmacotherapeutics specifically targeted
to cells experiencing a non-lethal oxidative stress environment.
Results
Ultrastructural, mitochondrial and calcium homeostatic
alterations induced by chronic minimal peroxide (CMP)
Application of various doses of H2O2 (10 nM or 10 mM) for
seven days to SH-SY5Y cells resulted in a strong re-organization of
both actin and tubulin into highly ordered superstructures
(Figure 1A). Similar structural changes, compared to control cells,
were seen for 10 nM (Figure 1A, 4, 5, 6) and 10 mMH 2O2
(Figure 1A: panels 7, 8, 9) indicating that qualitatively similar
effects were seen with the chronic minimal peroxide (CMP: 10 nM
H2O2, seven day exposure) and higher peroxide doses. Under
higher resolution, CMP treatment, compared to control, induced
the formation of classical actin stress fibres (Figure 1B, 1–2)
polymerized microtubule structures (Figure 1B, 3–4). Along with
cytoskeletal alterations we also assessed the effects of the CMP
paradigm upon another primary cellular compartment often
linked with oxidative stress, i.e. mitochondria. Using Mitotracker
(10 nM) to identify mitochondrial expression we noted a
significant reduction of Mitotracker-fluorescence (Figure 1B,C) in
cells exposed to the CMP paradigm. The extant mitochondria in
CMP-treated cells appeared functional when assessed using
tetramethylrhodamine ethyl ester-associated fluorescence (data
not shown). In addition to this alteration of energy-controlling
organelles we also investigated the ability of CMP cells to uptake
and utilize glucose. CMP-treated cells, compared to control,
demonstrated a significant reduction of glucose uptake (Figure 1D)
as well as reductions of membrane GLUT 1 and 2 transporter
expression (Figure 1E). In addition, we determined the metabolic
fate of glucose in CMP cells and found that CMP treatment
induced a proportional increase in lactate production for a given
level of glucose uptake after introduction of a 5 mM bolus dose
(4 hours) (Figure 1F).
CMP-induced alterations of calcium homeostasis
Using the membrane-permeant calcium sensitive dye, Fluo-
4AM, a significantly elevated resting calcium level was identified in
CMP-treated SH-SY5Y cells (Figure 2A). CMP cells were still able
to respond to excitatory glutamate however. In both CMP and
control cells glutamate stimulation resulted in long-lasting
increases in Fluo-4AM signal intensity (Figure 2B) with the
maximal Fluo-4AM signals occurring more rapidly in CMP cells
compared to control. We investigated two ion channel mecha-
nisms that could contribute to the high resting calcium level in the
CMP cells, i.e. the plasma membrane voltage-gated calcium
channels (VGCC) and the sarco/endoplasmic reticulum calcium
channels (SERCA). VGCCs facilitate increases of cytoplasmic
calcium via influx from the extracellular space, while SERCA
channels actively modulate resting cytoplasmic calcium levels by
removal of cytoplasmic calcium to endoplasmic reticulum stores.
Selective chemical blockade of the L- and N-type VGCCs, with
nifedipine and v-conotoxin GVIA respectively, was used to
investigate the role of VGCCs in the elevated Fluo-4AM intensity
in CMP cells. After steady-state Fluo-4AM loading, L- or N-type
VGCC blockade, with nifedipine (10 mM: Figure 2C) or conotoxin
GVIA (Figure 2D) respectively, induced a progressive reduction
(5–20 minutes) of Fluo-4AM fluorescence in CMP compared to
control cells (Figure 2C, D). Therefore the high resting Fluo-4AM
cytoplasmic intensity in CMP cells is in-part mediated by L and N-
type VGCC influx. A chemical inhibitor of the SERCA 1 channel,
cyclopiazonic acid (CPA: 100 mM), was used to investigate the role
of cytoplasmic clearing in CMP cells. Upon application of CPA to
the Fluo-4AM-loaded CMP cells, a strong increase in the
cytoplasmic Fluo-4AM fluorescence, compared to control cells,
was observed suggesting an elevated calcium transfer process in
CMP cells (Figure 2E, F). To investigate the ability of CMP cells to
maintain cellular function in the face of changes in calcium flux we
assessed basic electrophysiological properties of CMP cells. CMP
and control cells were current clamped and subjected to 20 pA
steps of current (220 to +100). Both control and CMP cells
exhibited abortive action potentials typical of undifferentiated SH-
SY5Y cells (Figure S1A [41]), indicating that CMP treatment had
not modified whole-cell excitability. To assess changes in K
+
channel conductance, cells were voltage clamped at 240 mV and
exposed to +10 mV voltage steps (range, 240 mV to +120 mV).
Steady state K
+ channel conductance I/V plots for CMP and
control cells (Figure S1B) demonstrated that K
+ channel
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investigated whether CMP treatment affected plasma membrane
integrity. Classical passive membrane properties of cells: resting
membrane potential, input resistance, access resistance and
membrane capacitance are useful measures for assessing cell
health, membrane integrity, and membrane size. No significant
differences in any of these membrane parameters between CMP
or control cells was evident, indicating a relatively subtle action of
the CMP paradigm (Figure S1C).
CMP induces differential responsiveness to receptor
ligands
As we have assessed the electrical excitability of the CMP cells,
we next investigated the ability of CMP cells to respond to
exogenous chemical stimulants. We investigated the activity of
multiple transmembrane receptor systems that possess neuromod-
ulatory or neurotrophic actions. Stimulation of control or CMP
cells with dopamine (DA), b-methylcholine (MeCh), histamine
(HA), lysophosphatidic acid (LPA), anandamide (ADA) and brain-
derived neurotrophic factor (BDNF) was measured by assessment
of ligand-induced extracellular signal-regulated kinase 1/2
(ERK1/2), c-Src or Akt-1 activation. In CMP-treated cells a
significant potentiation of ERK1/2 activation induced by MeCh,
HA, LPA and ADA (Figure 3A: DA, HA, LPA, ADA-Figure S2)
was evident. In contrast to ERK1/2 results, MeCh-mediated c-Src
auto-tyrosine-418 phosphorylation was diminished in CMP cells
compared to control (Figure 3B: DA, HA, LPA, ADA-Figure S2).
BDNF-induced ERK1/2 and c-Src activation were attenuated in
CMP cells compared to control (Figure 3A,B). BDNF-induced c-
Src activation was also diminished in CMP cells versus control
(Figure 3B). A prime molecular function of BDNF is the activation
of neuroprotective Akt-1. As with many GPCR-based ligands little
basal Akt-1 activation was noted with MeCh (Figure 3C). BDNF-
induced Akt-1 activation in CMP cells was severely attenuated
compared to control cells (Figure 3C). The differential activity of
the CMP paradigm between the GPCR ligand activity and BDNF
presented an interesting divergence in action of CMP.
CMP-mediated transcriptome alterations in SH-SY5Y cells
The effects of the CMP protocol upon basal gene transcription
was investigated (Table S1). Inspection of the basal transcriptome
differences between CMP and control cells revealed the significant
regulation of multiple genes implicated in neurodegenerative
processes (SPAST, SACS, FKTN, DOPEY2, ALS2CR14, RTN3,
BLZF1, SFRS11, AHR, ARPP-19, B2M), control of cytoskeletal
dynamics (PTMA, DAPP1, HMMR, CAPZA1) and age-related
energetic/metabolic changes (TSC1, LARS, MSTO1, LEP, SBDS).
Using unbiased functional Gene Ontology/KEGG pathway gene
clustering we revealed strong population of GO-term groups
involved in protein synthesis (cysteinyl-tRNA aminoacylation), energy
regulation (glycoprotein catabolism), nucleo-cellular transport process-
es (regulation of NF-kB import into nucleus) and neuronal differentiation
(Notch signaling pathway) (Table 1). KEGG pathway analysis of
CMP-regulated genes revealed significant population of functional
signaling pathways including: protein synthesis (Ribosome); neuro-
physiology (Alzheimer’s disease, neurodegenerative disorders, long-term
depression); energy regulation (urea cycle/metabolism of amino acids);
metabolic signaling (insulin/mTOR signaling pathways) and pathways
linked to cellular architecture (focal adhesion) (Table 2). Using
MeSH-database analysis of the gene-disorder association strengths
of the CMP-controlled geneset we found that the geneset is likely
to be linked to energy regulatory (Type II diabetes), neurodegener-
ative (dementia, Parkinson’s disease, mental retardation) and cardiovas-
cular disorders (coronary artery disease, adult respiratory distress syndrome)
typically found in subjects experiencing long-term stress effects
(Table 3). We also used a new bioinformatic approach (latent
semantic indexing, see Materials and Methods) to illustrate the
functional connectivity between multiple CMP-regulated genes.
We constructed an interrogation-term matrix for the significantly
regulated CMP geneset (Table S1). This matrix investigated links
between potentially CMP-related functions (‘energy regulation’,‘ Ca
2+
regulation’,‘ glucose metabolism’, ‘mitochondria’, ‘aging’, ‘oxidation’‘ neuro-
degeneration’ and ‘stress’) and the transcriptomic response (Figure S3:
Table S1). Two genes were linked to seven out of eight terms
(DNM1L, ENDOG) and five genes were linked to six terms
(MINPP1, TSPO, SPTLC1, NNT, IHPK1). Interestingly all of these
have been implicated in long-term stress responses, aging and age-
related neurodegenerative disorders.
As we noted a divergent effect of CMP-treatment upon BDNF
versus MeCh signaling, we investigated whether the basal CMP-
transcriptome effects or early gene responses to these ligands also
demonstrated this. Firstly, several important functional genes linked
to neurotrophic receptor tyrosine kinase signaling were observed to
be downregulated by CMP, e.g. BEX1, TOB1, GSK3b, GRB2 and
SH3KBP1 (Table S1). We used latent semantic indexing in an
‘oppositional’ experimental approach (GeneIndexer-Materials and
Methods) to identify trends in the CMP-controlled geneset that may
underpin the potential bias in BDNF versus MeCh signaling and
also illustrate the overall phenotype of the CMP-mediated
transcriptome. Interrogation of the CMP-induced geneset with
the oppositional terms ‘BDNF’o r‘ acetylcholine’ demonstrated that
eleven significantly CMP-regulated genes were implicitly associated
with ‘BDNF’ (cumulative LSI correlation score of 1.787) compared
to only 2 genes associated with ‘acetylcholine’ (LSI score, 0.313)
(Figure 4A; Table S2). Interrogation with the terms ‘neurotrophin
receptor’ (42 genes, cumulative LSI correlation score of 8.573: Table
S2) versus ‘G protein-coupled receptor’ (4 genes, cumulative LSI
correlation score of 0.715) also demonstrated a bias of the CMP-
induced geneset (Figure 4B). As our CMP regimen is designed
primarily to mimic long-term oxidative stress responses, that may
Figure 1. Peroxide treatment of SH-SY5Y cells affects cellular architecture, mitochondrial expression and glucose uptake. A SH-SY5Y
cells treated with various concentrations of hydrogen peroxide for seven days or vehicle control (control – 1–3; 10 nM chronic minimal peroxide ‘CMP’
– 4–6; 10 mM – 7–9) were subsequently stained with Alexafluor-568-phalloidin, for b-actin visualization and counterstained with anti-a-tubulin
(middle column). A merge of the fluorescent signals created is also represented. B High resolution depiction of effects upon cytoskeletal (1, 2) and
microtubular (3, 4) architecture of CMP (10 nM hydrogen peroxide, 7 days) or vehicle (control) treatment. C CMP- (10 nM hydrogen peroxide, 7 days)
or vehicle-treated (control) SH-SY5Y cells stained with Mitotracker (10 nM). D Quantitated Mitotracker fluorescence from control or CMP-treated cells.
Results represent mean 6 standard error mean (SEM) of Mitotracker fluorescence from 10 cells/microscopic fields (n=3 fields). Mitotracker signal
intensity ((AU-B)/px
2) is quantified as arbitrary units (AU) – background (B) per square visual pixel (px
2). E Glucose-deprived SH-SY5Y cells treated with
either vehicle control (control) or CMP were assessed for bolus (20 mM) glucose uptake (n=3). Glucose concentration of the extracellular media was
assessed at the time points indicated after bolus application. F CMP-mediated alteration of GLUT1 or GLUT2 expression. GLUT expression measured
as normalized arbitrary absorbance units (ABU). G CMP-mediated reduction of cellular glucose uptake after 4 hours of bolus glucose (5 mM: left
panel) and lactate production was measured and normalized to the glucose uptake over a 4 hour period (right panel). Statistical significance was
measured using a Student’s t-test (GraphPad Prism v.3): * - p,0.05; ** - p,0.01; *** -p,0.001. This notation is used consistently throughout.
doi:10.1371/journal.pone.0014352.g001
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terms to investigate these potential effects of our process.
Interrogation of the CMP dataset with the terms ‘aging’ versus
‘juvenile’, showed that the significant gene number and LSI score
was considerably greater for ‘aging’ (18 genes, LSI score 2.498)
compared to ‘juvenile’ (4 genes, LSI score 0.577) (Figure 4C, Table
S2). We also compared the interrogation of the CMP dataset with
aging-related neurological disease terms versus terms for diseases
not usually linked to the aged. Considerably higher gene
representative (number) and LSI correlation scores were observed
for terms linked to aging-related disorders and pathophysiology (e.g.
Alzheimer’s disease) compared to terms linkedto disorders that tend
to be prevalent in the young or are congenital (e.g. ‘attention-deficit
deficiency disorder’) (Figure 4D, Table S2).
CMP treatment affects dynamic genomic responses to
ligand stimulants
In addition to investigating the static genomic effects of the
CMP paradigm we investigated how the static changes we
observed may affect dynamic cellular responses, or previously
identified bias, to activating ligands. Control or CMP-treated cells
were treated with MeCh or BDNF for 2, 4 or 8 hrs and the
transcriptional effects were subsequently measured (Tables S3, S4,
S5, S6, S7, S8 MeCh; Tables S9, S10, S11, S12, S13, S14 BDNF).
Organizing genes, significantly regulated (up-red: down-green) by
either BDNF or MeCh stimulation in both control or CMP cells,
into heatmaps demonstrated several areas of considerable
regulatory deviation between these two states for BDNF compared
to MeCh treatment (Figure 5A). BDNF- or MeCh-induced
genesets were separated into up (U)- or down (D)-regulated
groups across the multiple time points (2, 4, 8 hours). To assess the
effects of CMP on BDNF or MeCh-induced gene transcription, we
calculated the percentage of regulated gene identity retained
between the ligand-induced transcriptional effects in control
compared to CMP cells (Figure 5B). In addition to analyzing the
ligand-mediated gene regulation we also clustered the BDNF and
MeCh-regulated genes into significantly-populated GO-term
(Figure 5C) and KEGG pathway groups (Figure 5D). Comparing
the percentage similarity (between CMP and control conditions) of
BDNF and MeCh-mediated gene regulation, GO-term group
population and KEGG pathway population, we found that the
BDNF-mediated effects were consistently the most affected by
Figure 3. CMP treatment of SH-SY5Y cells affects intermediary cell metabolic responses to stimulatory ligands. Representative
western blots and associated histograms depict the changes in ERK1/2 (A), c-Src (B) and Akt-1 (C) activation in response to b-methylcholine (MeCh,
10 nM) or brain-derived neurotrophic factor (BDNF, 10 ng/mL) stimulating ligands in both control (blue bars) or CMP-treated (red bars) SH-SY5Y cells.
The time courses (0-60 minutes) for stimulation are denoted in the associated histograms depicting the mean 6 SEM from at least three separate
experiments. Statistical significance is indicated for changes in kinase activity in the CMP state relative to their time-matched control in vehicle-
treated (control) cells. Statistical significance was measured using a Student’s t-test (GraphPad Prism v.3): * - p,0.05; ** - p,0.01.
doi:10.1371/journal.pone.0014352.g003
Figure 2. Chronic minimal peroxide treatment modification of calcium homeostasis. A Basal and glutamate (50 mM)-stimulated increase
of intracellular Fluo-4 fluorescence intensity in control or CMP cells. B Graphical representation of calculated intracellular calcium (nM) changes
following 50 mM glutamate exposure (60 minutes) for CMP or control SH-SY5Y cells. Mean 6 SEM fluorescent calcium measurements were taken from
10 cells/microscopic field (n=3 fields). C Changes in intracellular calcium Fluo-4 fluorescent intensity resulting from 10 mM nifedipine exposure (30
minutes) for CMP or control SH-SY5Y cells. The associated histograms depict the resultant changes of calcium levels and intracellular Fluo-4 intensity
(relative to time=0 minutes), over time in response to nifedipine treatment. Fluo-4 intensity and calcium measurements for each time point were the
average from 10 cells/microscopic field (n=3 fields). D Changes in intracellular Fluo-4 fluorescent intensity resulting from 1 mM v-conotoxin exposure
(30 minutes) for CMP or control SH-SY5Y cells. The associated histograms depict the resultant changes of calcium levels and intracellular Fluo-4
intensity (relative to time=0 minutes), over time in response to nifedipine treatment. Fluo-4 intensity and calcium measurements for each time point
were the average from 10 cells/microscopic field (n=3 fields). E Confocal Fluo-4 intensity images from control-treated SH-SY5Y cells or CMP-treated
SH-SY5Y cells at various time points before (t=0) and after (t=10, 90 minutes) exposure to the SERCA channel blocker, CPA (100 mM). Panel F,
intracellular calcium concentration and percentage changes in calcium Fluo-4 intensity versus their individual controls (t=0) for control or CMP-
treated cells. Values depicted represent the mean 6 SEM, measured as mean from 10 cells/microscopic field: n=3 fields.
doi:10.1371/journal.pone.0014352.g002
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percentage similarity between BDNF effects in CMP cells
compared to control cells. Many of the BDNF/MeCh-regulated
genes controlled in both CMP and control states (Figure S4). We
therefore assessed if there were any differences in the polarity (up
or downregulation) of control for BDNF or MeCh in CMP versus
control states. Genes regulated by BDNF or MeCh in both CMP
and control states were organized into coherent series (numbered
Table 1. Gene Ontology (biological process) analysis of CMP-mediated geneset alteration compared to control SH-SY5Y cell
geneset.
GO-bp Enrichment R (O/E) Probability (p) Hybrid
Protein synthesis
cysteinyl-tRNA aminoacylation 50 4.79E-04 165.9832
snRNA processing 8.33 2.30E-02 13.64681
translation 3.44 1.09E-04 13.63125
mRNA catabolism 6 1.32E-02 11.27656
transcription from RNA polymerase III promoter 5.45 1.66E-02 9.700411
nuclear mRNA splicing\, via spliceosome 3.23 1.11E-03 9.543607
translational initiation 3.94 8.57E-03 8.144056
tRNA aminoacylation for protein translation 4.26 1.41E-02 7.884327
rRNA processing 3.09 2.28E-02 5.073981
Cell cycle control
G2 phase of mitotic cell cycle 22.22 2.77E-03 56.8281
mitotic spindle checkpoint 15.38 6.74E-03 33.39521
interphase of mitotic cell cycle 3.82 9.86E-03 7.66339
interphase 3.62 1.20E-02 6.953364
negative regulation of progression through cell cycle 2.44 1.20E-02 4.686798
mitosis 2.33 2.20E-02 3.862155
M phase 2.05 3.26E-02 3.047904
Energy regulation
glycoprotein catabolism 12.5 1.50E-03 35.29886
aerobic respiration 4.29 3.21E-02 6.407093
energy reserve metabolism 3.8 4.34E-02 5.177539
Cellular transport
axon cargo transport 13.33 9.29E-03 27.08635
proline biosynthesis 13.33 9.29E-03 27.08635
regulation of NF-kappaB import into nucleus 8.33 2.30E-02 13.64681
regulation of transcription factor import into nucleus 5.71 4.67E-02 7.598201
protein import into nucleus 3.7 1.13E-02 7.20361
Neuronal differentiation
positive regulation of cell differentiation 9.68 3.14E-03 24.22972
regulation of neuron differentiation 9.09 1.91E-02 15.62541
negative regulation of cytokine biosynthesis 9.09 1.91E-02 15.62541
regulation of neurogenesis 6.06 4.14E-02 8.380978
Notch signaling pathway 4.05 3.75E-02 5.775173
cell motility 2.36 5.21E-03 5.388263
microtubule-based process 2.4 1.92E-02 4.120077
generation of neurons 2.66 4.00E-02 3.71852
DNA metabolism
base-excision repair 6 1.32E-02 11.27656
DNA recombination 3.95 1.93E-03 10.72205
pyrimidine nucleotide metabolism 4.41 2.96E-02 6.741604
nucleosome assembly 3.13 1.25E-02 5.956672
DNA replication 2.11 3.73E-02 3.013694
doi:10.1371/journal.pone.0014352.t001
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and time scale of regulation (Figure 6A, B: Tables S15, S16, S17
(MeCh) and S18–S20 (BDNF)). For MeCh stimulation, only two
genes regulated in both CMP and control conditions demonstrated
a reversal of their polarity (Figure 6A). In contrast, for BDNF
stimulation, the polarity of regulation was reversed for seventy
nine genes between CMP and control states (Figure 6B). Many of
these ‘reversed-polarity’ BDNF-controlled genes are involved in
protein metabolism/synthesis (e.g. RPL14), energy regulation (LEP,
DLDH) the aging process (HMGB2, PTMA) as well as age-related
neurodegeneration (YY1, HIF1A, TIA1, RTN3). We also noted that
within the specific regulation series (1–4: Figure S5) the modulus of
the differences in gene regulation z-ratios (between CMP and
control states) was greater for BDNF-controlled compared to
MeCh-controlled genes (Figure S5). Therefore, at multiple and
detailed levels of investigation the CMP protocol exerts a
preferential alteration of neurotrophin receptor activity compared
to GPCR activity. The repetition of these subtle effects in multiple
biochemical aspects may be indicative of how signaling connec-
tivity and adaptive responses can pervade diverse aspects of
cellular function, especially in cases of stressful perturbations.
Minimal oxidative stress induces signaling network and
proteomic alterations in SH-SY5Y cells
As we have demonstrated specific signaling and transcriptomic
changes, we next assessed CMP-mediated protein alterations at
the signaling network and global proteomic level. PanoramaH Cell
signaling array antibody chips were used to investigate the specific
changes simultaneously in a wide array of signal transduction
factors. Control or CMP-treated whole-cell lysates were separately
labeled with either Cy3 or Cy5 and then mixed and hybridized
with the cell signaling array chips. The criteria for designation of
significant up or down-regulation of proteins using the array is
described in the Materials and Methods section. A sample of a
scanned signaling array is depicted in Figure 7A. The relative
protein expression changes between the control and CMP samples
were calculated for multiple experiments (Figure 7B; Table S21).
In accordance with our previous data (Figure 3, Figure S2) we
found a generalized suppressive effect of CMP upon signaling
functions (66.7% of singificantly-regulated proteins were down-
Table 2. KEGG pathway analysis of CMP-mediated geneset alteration compared to control SH-SY5Y cell geneset.
KEGG Pathway Enrichment R (O/E) Probability (p) Hybrid
Protein synthesis
Ribosome 8.6059 2.70E-07 56.52903
Aminoacyl-tRNA biosynthesis 7.9957 6.15E-03 17.67949
Folate biosynthesis 6.3546 1.17E-02 12.27591
Ubiquitin mediated proteolysis 5.7637 1.52E-02 10.47931
Neurophysiology
Alzheimer’s disease 11.8017 1.99E-03 31.87813
Dorso-ventral axis formation 9.5329 3.72E-03 23.15977
Neurodegenerative Disorders 7.2904 7.98E-03 15.29524
Long-term depression 4.3483 1.37E-02 8.102098
Gap junction 3.888 1.99E-02 6.614059
Cellular metabolism
Sulfur metabolism 12.7065 1.04E-02 25.19657
Urea cycle and metabolism of amino groups 6.8847 3.38E-02 10.12797
Inositol phosphate metabolism 5.3879 1.82E-02 9.374561
Arginine and proline metabolism 4.6765 2.64E-02 7.381369
Pyrimidine metabolism 3.713 2.31E-02 6.075909
Purine metabolism 2.8293 3.28E-02 4.199038
Cellular signaling
Insulin signaling pathway 4.4487 1.07E-03 13.21538
mTOR signaling pathway 5.2733 1.93E-02 9.040771
Fc epsilon RI signaling pathway 4.4658 1.25E-02 8.498819
Hedgehog signaling pathway 4.59 2.77E-02 7.149018
Cellular architecture
Cell cycle 4.4659 2.36E-03 11.73231
Focal adhesion 3.4786 2.31E-03 9.170939
Cell Communication 3.9342 9.12E-03 8.025788
Apoptosis 4.08 1.69E-02 7.230222
ECM-receptor interaction 4.0302 1.77E-02 7.061018
Regulation of actin cytoskeleton 2.0969 9.21E-02 2.171844
doi:10.1371/journal.pone.0014352.t002
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involved in neuronal signaling and transmission (tryptophan
hydroxylase; syntaxin; synuclein; MAP2; iNOS; connexin 32; adaptin)
and calcium homeostasis/regulation (calnexin) was noted. In
addition a strong CMP-mediated alteration in the expression of
proteins that possess a duality of function, i.e. positively promote
neuronal activity as well as facilitate the initiation of cell death
activities (SMAC/DIABLO; c-ABL; Apoptosis-inducing factor; CDC25;
p57KIP2) was observed. To generate a predicted functional
network of these CMP-regulated factors we employed a net-
work-developing algorithm using Ingenuity Pathway Analysis (see
Materials and Methods). The highest probability predicted functional
network contained fourteen specific CMP-regulated proteins (APP,
CALR, CANX, CTNND1, EGFR, ESR1, GJB1, H3F3A (includes
EG:3020), MAP1A, MAPK8, NOS2, NUTF2, RAN, TUBA4A) and
was most closely related to the following physiological functions:
Nervous System Development and Function; Cell Morphology; Cell-To-Cell
Signaling and Interaction (Figure S6, Table S22).
To appreciate the potential adaptive cellular responses to the
CMP paradigm in a non-platform-based proteomic format, we
employed two-dimensional in-gel electrophoresis (DIGE) to
investigate CMP-induced global proteomic changes. Global
proteomic changes were assessed for extended exposure to
multiple peroxide concentrations, including our CMP paradigm
(10 nM, seven days: Figure 8A). We found that .80% of the
proteins altered by peroxide treatment were seen consistently
across the different peroxide concentrations. Proteins with reliable
(n=6 per H2O2 concentration: $20% expression change) and
quantitatively significant expression changes in response to the
specific CMP protocol were excised and identified using LC-MS/
MS (ThermoFinnigan LXQ) (Figure 8B). The identities of the
reliably-regulated CMP-controlled proteins are displayed in
Tables 4 and 5. To predict the global functional nature of the
CMP-regulated protein set, we employed an unbiased bioinfor-
matic approach. CMP-regulated proteins were clustered (see
Materials and Methods for criteria) into gene ontology (GO) groups
(Table 6) and KEGG (Kyoto Encyclopedia of Genes and
Genomes) signaling pathways (Table 7) using parametric gene
set enrichment analysis (WebGestalt). The most significantly
CMP- populated GO-biological process term clusters were linked
to: energy regulation (anaerobic glycolysis); neuronal development
(regulation of synaptic plasticity, neuron differentiation); small G protein
signaling (Rho protein signal transduction); translational control
(translational elongation); protein metabolism (cytoskeleton and organelle
organization and biogenesis) and cell cycle/apoptosis (Table 6). The
most significantly CMP-populated KEGG pathways demonstrated
a strong metabolic (glycolysis/gluconeogenesis), disease-related (Hun-
tington’s Disease) and cell-signaling (calcium signaling pathway, Wnt
signaling pathway) association (Table 7). We also found that the
genes encoding the CMP-regulated proteins were heavily clustered
on human chromosome 2 (Figure S7). Using chromosomal gene-
disease locus association (www.genecards.org), we identified 246
individual disease-related loci found on human chromosome 2,
and out of the 91 loci affected by CMP, 46 were associated with
glucose/energy regulation and 45 were associated with neurode-
generative/neurological mechanisms. This may suggest the
presence of coherently-regulated gene/protein groups that re-
spond to long-term peroxide-mediated stress. To transfer our
proteomic DIGE findings from CMP treatment to more
standardized techniques, we randomly chose several proteins
(calreticulin, GIT-2, GAPDH, calmodulin, lamin, 14-3-3 zeta)
whose expression was elevated or reduced by CMP treatment to
demonstrate their direct peroxide responsiveness. We found a
strong recapitulation of the DIGE-measured effects on both the
up- or downregulated proteins with western blot analysis
(Figure 8C: Tables 4–5). To further investigate these proteins,
and how they may relate to long-term stress exposure, we assessed
their expression patterns in young versus aged mammalian cortical
tissue from multiple sources, i.e. rat, rhesus macaque and human.
We hypothesized that the aged animals, compared to the younger,
were more likely to have experienced longer term exposure to
stressors such as oxygen radicals. Therefore young versus aged tissues
may possess an analogous protein expression profile to control
versus CMP cells respectively. When applying our analytical
Table 3. Medical subject heading term analysis of CMP-
mediated geneset alteration compared to control SH-SY5Y
cells geneset.
MeSH Disease Terms Z Score
Musculoskeletal
ARTHRITIS__JUVENILE_RHEUMATOID 4.300434
OSTEOARTHRITIS 0.461885
Diabetes – Energy regulatory
DIABETES_MELLITUS__TYPE_2 2.002813
DIABETIC_NEPHROPATHIES 1.562933
HYPERINSULINISM 1.006024
HYPERTRIGLYCERIDEMIA 0.79994
Neurodegeneration
DEMENTIA 1.969758
CEREBROVASCULAR_ACCIDENT 1.812081
ATROPHY 1.423247
PARKINSON_DISEASE 1.275841
BRAIN_ISCHEMIA 1.071663
CEREBELLAR_ATAXIA 0.746189
CHARCOT-MARIE-TOOTH_DISEASE 0.714724
MENTAL_RETARDATION 0.414224
DNA instability
CHROMOSOME_ABERRATIONS 1.870107
Cardiovascular disorders
CORONARY_ARTERY_DISEASE 1.845112
MYOCARDIAL_INFARCTION 1.434788
CAROTID_ARTERY_DISEASES 1.33356
RESPIRATORY_DISTRESS_SYNDROME__ADULT 1.211369
VASCULAR_DISEASES 1.035383
Protein metabolism disorders
PROTEINURIA 1.843715
ALBUMINURIA 1.579696
Neoplastic disorders
SKIN_NEOPLASMS 1.3896
PHARYNGEAL_NEOPLASMS 1.318447
METAPLASIA 1.08451
LYMPHOMA 0.903678
ADENOMATOUS_POLYPOSIS_COLI 0.893777
Renal disorders
HEPATITIS__TOXIC 1.048206
Cumulative Z scores are derived from the positive associations of significantly
regulated genes that populate the denoted MeSH groups obtained from the
National Library of Medicine (http://www.ncbi.nlm.nih.gov/mesh).
doi:10.1371/journal.pone.0014352.t003
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months), rhesus macaque (Figure 8E: young, 15–17 years; aged, 31–
35 years) and human (Figure 8F: young, 22–25 years; aged, 82–85
years) cortical tissue, we noted similar (except for GAPDH
regulation in human cortex) protein expression changes to those
we observed using our CMP model (Figure 8C, Tables 4–5).
Discussion
We have attempted to create a viable cell model of long-term,
low-level oxidative stress and use this to investigate, at multiple
levels, the alterations of cellular function and physiology imposed
by this tolerable insult. The chronic minimal peroxide (CMP)
protocol induced adaptive changes in SH-SY5Y cells that could
aid research into long-term cellular damage and stress in vivo. The
CMP regimen caused profound cytoskeletal re-organization,
reduction of mitochondrial expression, attenuation of glucose
uptake elevated basal calcium and c-Src activity, as well as changes
in the transcription of genes and expression of proteins linked to
energy alteration and neurodegenerative processes. In contrast to
more deleterious levels of peroxide exposure ($0.1 M), CMP did
not significantly affect membrane electrophysiological parameters
or responses to excitatory amino acids. This subtle model of long-
term cellular stress may provide a useful addition to bioscreening
processes, especially when studying highly complex events such as
ligand response profiles or protracted physiological processes.
Obviously different cellular models of long-term cellular stress
could be employed. Each model will possess its own unique
advantages and drawbacks. The advantages of using a clonal cell
culture, such as SH-SY5Y cells, are that cultures will be consistent,
easy to maintain, possess a human phenotype and can be readily
used for large-scale drug-screening. Some of their drawbacks
include, variation in cell phenotype with passage and their
neuroblastoma lineage. On the other hand, primary neuronal
Figure 4. CMP treatment exerts a biased effect upon gene transcription in SH-SY5Y cells. A–C The CMP-responsive significantly-
regulated geneset was interrogated using latent semantic indexing (GeneIndexer) of input terms. The number of implicitly correlated genes ($0.1
latent semantic indexing correlation score) are denoted for each interrogation term (red bar section=upregulated genes; green bar
section=downregulated genes) as well as the total correlation score for those genes (italic next to colored bar). The specific interrogation term
(A- BDNF vs. Acetylcholine: B- Neurotrophin receptor vs. G protein-coupled receptor: C- Aging vs. juvenile) are denoted in each panel A–C. D Latent
semantic indexing scores and number of genes associated with aging/degeneration disease-related interrogation terms (senescence, Parkinson’s
disease, neurodegeneration, Huntington’s disease, Cognitive impairment, Amyotrophic lateral sclerosis, Alzheimer’s disease) compared to ageing-
independent disorders (Tourette syndrome, Spina bifida, measles, asthma, ADHD, achondroplasia). The number of implicitly-associated genes are
indicated in the colored horizontal bars as well as the cumulated latent semantic indexing scores (italic).
doi:10.1371/journal.pone.0014352.g004
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they may not be suitable for large-scale drug screening for the
following reasons, i.e. costly and labor-intensive preparation,
variation of culture and cell populations between animals and
embryonic tissue usage. It is clear that different models offer
different possibilities and not one will be able to suit all needs. The
choice of the model system will be strongly influenced by the
nature of the intended investigation.
CMP treatment, at multiple levels was able to engender a strong
recapitulation of multiple aspects of long-term cell stress that could
represent a limited molecular proxy for aging or neurodegener-
ative processes. CMP treatment mimicked aging/neurodegenera-
tive changes in cytoskeletal architecture [42,43], impaired
mitochondrial activity and biogenesis [44–48], altered glucose
uptake/mobilization [49–53], disrupted calcium homeostasis
[54–61], and alterations in energy management systems [62–64].
In addition, multiple CMP-induced genomic changes were linked
to protracted stress, energy and calcium regulation as well as
neurodegenerative processes, e.g. DNM1L [65,66], SPTLC1
[67,68]) and ENDOG [69]. Relatively novel CMP-controlled
factors linked to neurodegeneration were uncovered, e.g. APAF1-
interacting protein (APIP: [70,71]) which typically protects against
hypoxic-related cell damage but was downregulated in response to
CMP (Table S1). Inositol hexakisphosphate kinase 1 (IHPK1),
which catalyses the creation of higher forms (hexaphosphates)
from inositol (1,4,5) trisphosphate, has been linked to cellular and
somatic energy management [72–75]. We noted a CMP-mediated
potentiation of IHPK1 expression (Table S1: Figure S3) and it has
been demonstrated that elevated cortical expression of IHPK1
occurs in an in-bred murine model of accelerated aging
(senescence-accelerated mouse/prone 8 (SAMP8: [76]). The
SAMP8 mouse demonstrates reduced lifespan compared to
control normal-aging SAMR1 mice [76] as well as age-related
cognitive decline in a manner reminiscent of Alzheimer’s disease
[77,78]. Application of therapeutics, demonstrated to improve
ischemia-induced disrupted spatial cognition and central neuronal
cholinergic function [79], to this model were shown to reduce the
elevated levels of cortical IHPK1, resulting in amelioration of the
SAMP8 cognitive deficits [80].
Suggesting a potential systemic connection between long-term
oxidative stressors and age-related disorders we noted a strong
clustering of the genes for CMP-controlled proteins on chromo-
some 2. This chromosomal region contains a considerable number
of loci that have been associated with the induction of age/stress-
related diseases [81–86]. In addition, using an antisera chip
approach we demonstrated CMP-induced expression changes of
signaling proteins closely associated with long-term stress and
aging/neurodegenerative processes including: synuclein; syntaxin;
SNAP-25; p57KIP2; RAN; AKT-1; p120 catenin; iNOS; estrogen
receptor; epidermal growth factor receptor; dystrophin; desmin;
connexin 32; cofilin; calnexin; c-Jun N-terminal kinase; c-ABL
[87–105]. Employing two-dimensional DIGE we were able to
generate a specific CMP proteomic response ‘signature’, indepen-
dent of pre-set protein targets. Bioinformatic analysis of this CMP
protein expression ‘signature’( i.e. reliably CMP-altered proteins)
revealed a strong energy-regulatory and potentially degenerative
phenotype of this dataset (Tables 6, 7). We assessed whether
protein targets, identified using DIGE, (calreticulin, GIT2,
GAPDH, calmodulin, lamin, 14-3-3 zeta: Figure 8) could be
indicative of advancing cellular stress associated with age. With
investigation of the age-related expression profile of these targets,
many of which are associated with long-term stress or aging itself
[106–110], in young versus aged rats, primates and humans, we
noted strong analogy between control versus CMP with young
versus aged states (Figure 8C–F). In addition to these signaling
protein alterations we also demonstrated a CMP-mediated
elevation in basal c-Src activity and GPCR-mediated ERK1/2
responses, both of which are linked to the aging/neurodegener-
ative process [111–116]. While GPCR activity in CMP cells was
both potentiated (ERK1/2) and attenuated (c-Src), for different
signaling effectors, neurotrophic BDNF signaling however was
consistently attenuated in the CMP state. Unbiased genomic
analysis of the effects of the CMP protocol demonstrated a geneset
bias towards disruption of neurotrophin signaling versus GPCR-
based signaling (Figures 4, 5, 6) and was more indicative of cells in
an aging/neurodegenerative state, compared to a young healthy
state (Figure 4). CMP caused a more profound disruption of the
early genotropic output from BDNF compared to MeCh
stimulation at multiple levels of investigation (Figure 5–6). Multiple
genes upregulated by BDNF in control conditions were downreg-
ulated by BDNF in CMP conditions (Figure 6, Tables S18, S19,
S20). Many of these genes possess multifactorial roles in the aging/
neurodegeneration process, e.g. PTMA, WSB2, RPL7, HMGB2,
DLDH and DDX17 [117–125]. In the CMP state the direction of
BDNF-mediated regulation of the transcription factor YY1 [126]
was reversed. In CMP cells BDNF downregulated YY1 transcrip-
tion factor while in control cells BDNF upregulated its expression.
YY1 expression can control iron-transferrin homeostasis in an age-
dependent manner [127], regulate cell senescence [128] and
Alzheimer’s disease-related amyloid processing [129]. Disruption
of BDNF-regulated YY1 transcription could therefore exert
multiple deleterious neural effects. BDNF transcriptional regula-
tion of T-complex 1 (TCP-1) was also reversed by CMP treatment
(reduction in CMP state, potentiation in control state). TCP-1 was
first identified as a molecular chaperone for tubulin. TCP-1
disruptions are associated with the accelerated aging in SAMP8
animals [130,131], synaptic disruption in murine Huntington’s
disease models [132] and is downregulated (as in CMP state) in
aging rat synapses [133]. BDNF-mediated upregulation of
hypoxia-induced factor-1 (HIF1A) in control cells was also reversed
with CMP cellular treatment (Figure 6B). BDNF typically controls
HIF1A expression through a phosphoinositide 3-kinase/mTOR-
dependent mechanism [134]. HIF1A has been associated with age-
related degenerative disorders, e.g. Alzheimer’s and Parkinson’s
disease [135] and genetic ablation of its expression significantly
accelerates the onset of cellular senescence [136]. Conversely,
Figure 5. CMP treatment differentially affects early genomic responses to BDNF and MeCh. A Heatmap diagram indicating differences in
global gene regulation (red-upregulation: green-downregulation) in control (black under bar) and CMP states (red under bar) for 2, 4 and 8 hours of
either BDNF or MeCh stimulation. B Significantly-regulated gene identity conservation between the CMP and control state for BDNF- (white bars) or
MeCh-stimulated (black bars) genesets separated into upregulated (2 hours up-2U; 4 hours up-4U; 8 hours up-8U) or downregulated groups (2 hours
down-2D; 4 hours down-4D; 8 hours down-8D). The percentage conservance between CMP and control state of significantly-regulated genes was
calculated as the percentage of total genes regulated in the specific CMP conditioned cells (2U, 4U, 8U and 2D, 4D, 8D) that were also significantly
regulated in the control state. E Significantly-enriched Gene Ontology biological process (GO-bp) term group conservance between CMP and control
state SH-SY5Y cells treated with either BDNF or MeCh. Histogram creation and structure is identical to that in panel D. F Significantly-enriched KEGG
pathway conservance between CMP and control state SH-SY5Y cells treated with either BDNF or MeCh. Histogram creation and structure is identical
to that in panel D.
doi:10.1371/journal.pone.0014352.g005
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animals exerts strong neuroprotective effects and can extend
lifespan [137,138]. Therefore, the CMP-induced reversal of
BDNF-mediated HIF1A regulation reproduces the pro-aging
HIF1A profile observed by multiple researchers. Altered neuro-
trophin receptor signaling has been linked to pathophysiologies
associated with stress and aging in multiple systems including
animal models as well as human epidemiological and post-mortem
data [29,139–148]. This may suggest that neurotrophin dysreg-
ulation may potentially be an important early effect in the
degenerative or aging processes. While this aging-neurotrophin
association has been the subject of intense research it is likely in the
future that additional, equally important, stress-response mecha-
nisms will also be uncovered. For this study we have focused on
Figure 6. Differential effects of CMP upon BDNF- or MeCh-regulated genes common to control or CMP cellular states. A MeCh-
significantly regulated (indicated by z ratio) genes common between CMP and control (CTRL)-treated SH-SY5Y cells. The top panel depicts polarity-
dependent series (1–5) of MeCh-regulated genes after 2 hours of stimulation, middle panel represents common CMP-control gene series (1–6) after
4 hours of stimulation while the lowest panel represents common CMP-control gene series (1–4) after 8 hours of stimulation. B depicts analogous
genomic data to panel A but for BDNF instead of MeCh. In both A and B the CMP-(MeCh or BDNF) regulated gene expression levels are denoted in
red while the control-(MeCh or BDNF) regulated gene expression levels are denoted in blue. For both BDNF or MeCh the gene regulation series are as
follows: series 1=upregulated in CMP and control with z ratio CMP.CTRL; series 2=upregulated in CMP/control with z ratio CTRL.CMP; series
3=downregulated in CMP/control with z ratio CMP,CTRL; series 4=downregulated in CMP/control with z ratio CTRL,CMP; series 5=upregulated in
CMP-downregulated in CTRL; series 6=downregulated in CMP-upregulated in control.
doi:10.1371/journal.pone.0014352.g006
Figure 7. Global cellular signal transduction analysis of neural response to chronic minimal hydrogen peroxide exposure. A
Representative Cy3/Cy5 protein-labeled cell signaling PanoramaH antibody microarray chip. Exemplary insets from experimental antibody chips are
highlighted indicating relative changes in Cy3 or Cy5 reactivity for the negative (unlabelled bovine serum albumin deposited on chip) and positive
control (Cy3/Cy5-labeled bovine serum albumin deposited on chip) chip area as well as for factors identified that demonstrate increased, decreased
or an unchanged expression between control and CMP conditions. Individual channel (Cy3 or Cy5 emission) fluorescent intensities are displayed
along with the merge colored channel. B Expression ratios (mean 6 SEM (n=4 arrays)) between proteins extracted from CMP-treated SH-SY5Y cells
compared to control. Protein expression greater in CMP compared to control (red bars) demonstrated an expression ratio of greater than 1.0 while an
expression ratio significantly less than unity indicated a reduced expression level induced by CMP (green bars).
doi:10.1371/journal.pone.0014352.g007
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aging and neurodegenerative disease. Clearly future work is
needed that will carefully characterize the effects of CMP upon
numerous other receptor-based cell signaling systems.
In conclusion, the CMP process creates a viable cell model for
the study of cellular responses to protracted, tolerable oxidative
stress. While limited by the nature of in vitro cultured neural cells
we have seen that molecular alterations induced by CMP may in-
part mirror those molecular changes seen in brain tissues that have
experienced long-term stress. In some ways this model may assist
in the understanding of the complex series of molecular
mechanisms involved in aging and neurodegenerative disease. It
is highly unlikely that any cellular model can completely
recapitulate such a complex multidimensional process, however
the CMP model recapitulates some of the correlated facets of the
physiological and pathophysiological aging process in experimen-
tal animals and humans. The CMP model demonstrates that at
multiple levels of experimental interrogation systemic alterations of
cellular function, that may act in concert to allostatically [149]
create a multi-dimensional phenotype that could be useful for
research into aging and neurodegeneration. The CMP phenotype
demonstrates itself at multiple levels of functionality, indicating a
profound depth of coherent cellular regulation. A greater
understanding of this multifactorial phenotype could lead to
improved cell-based assays for the screening and development of
therapeutics that target aging/neurodegenerative disorders.
Materials and Methods
Cell Culture and Treatment
SH-SY5Y, obtained from ATCC (http://www.atcc.org/), cells
were maintained at 37uC in a humidified 5% CO2 incubator in
AMEM/F12 supplemented with 10% FBS, 100 units/mL
penicillin/100 units/mL streptomycin. Cells of passage number
5–15, from ATCC, were used for all experiments to prevent any
alteration of growth or response phenotype. During experimen-
tation no significant changes of required passaging rates or gross
morphology were noted. Cells were treated with either phosphate-
buffered saline (PBS) (control), 10 nM, 100 nM, 1 mMo r1 0mM
hydrogen peroxide (H2O2: Sigma Aldrich, St Louis MO) for seven
days. Cell growth media and applied hydrogen peroxide
treatments were changed daily.
Mammalian Tissue Analysis
Animal care and experimental procedures followed NIH
guidelines and were approved by the National Institute on Aging
Animal Care and Use Committee. Male Sprague-Dawley rats
(ages 4 months, n=3: 24 months, n=3) were euthanized
humanely with isoflurane and cortical tissue was excised as
previously described [150]. Cortical tissue from male Rhesus
Macaque (ages 15–17 years, n=3: 31–35 years, n=3) was
obtained from the National Institute on Aging Division of Aging
Biology and the Wisconsin National Primate Research Center.
Human male post-mortem cortical tissue (ages 22–25, n=3: 82–
85 years, n=3) was obtained from an approved tissue source, i.e.
Integrated Laboratory Service–Biotech (Chestertown MD). Tissue
lysates were prepared from the mammalian tissues using the
Qproteome
TM tissue fractionation kit (Qiagen). Lysate concentra-
tions were measured using a standard BCA assay (Pierce-
ThermoElectron) and normalized to a 1 mg/mL concentration
before resolution by SDS-PAGE.
Western Blotting
For western blotting protocols cell monolayers were washed
once in ice-cold PBS and then lysed in an NP-40 based buffer
(250 mM NaCl, 5 mM HEPES, 10% v/v glycerol, 0.5% NP-40,
2 mM EDTA (pH 8.0), 100 mM NaVO4) supplemented with a
complete mini protease inhibitor cocktail (Roche Diagnostics,
Indianapolis, IN) [151]. Lysate concentrations were measured
using a standard BCA assay and normalized to 1 mg/mL total
protein then resolved using gel electrophoresis followed by
electrotransfer to polyvinylenedifluoride (PVDF: Perkin Elmer;
Waltham, MA). PVDF membranes were blocked for one hour at
room temperature in 4% non-fat milk (Santa Cruz; Santa Cruz
CA) before application of specific primary antisera. The presence
of primary antibody reactivity with the PVDF membrane was
detected by the application of a 1:5000 dilution of a species-
specific alkaline phosphatase-conjugated secondary antibody
(Sigma, St. Louis, MO). PVDF-bound immunecomplexes of
secondary and primary antibodies were subsequently detected
using enzyme-linked chemifluorescence (ECF: GE Healthcare;
Pittsburgh PA). Chemifluorescent signals from membranes were
quantified using a Typhoon 9410 phosphorimager (GE Health-
care; Pittsburgh PA). Specific primary antisera used were obtained
from the following sources: lamin-A, glyceraldehyde-3-phosphate
dehydrogenase (GAPDH), calmodulin, calreticulin, extracellular
signal-regulated kinase (ERK), c-Src, 14-3-3 zeta and beta-actin -
Santa Cruz Biotechnology, Santa Cruz, CA; GIT-2 - NeuroMab,
San Jose CA; tyrosine-418 phosphorylated c-Src - Invitrogen,
Carlsbad CA; phospho-ERK, phospho-Akt-1 and Akt-1 - Cell
Signaling Technology, Danvers MA).
Two-Dimensional Differential In Gel Electrophoresis
(DIGE)
GrowthmediawasaspiratedandcellswerewashedtwicewithPBS
before being lysed in 7 M urea, 4% CHAPS and 30 mM Tris,
pH 8.5 [152]. Samples wereagitated (30 minutes, RT) then sonicated
on ice and centrifuged (10minutes, 100006g). Supernatant was then
applied to a 3000 Da molecular weight cut-off centrifugation spin-
filter (Millipore, Billerica MA) to remove excess salts. Protein
concentrations were re-determined with a BCA assay and 15 mgo f
total protein from each sample was labeled with 0.3 mL (120pmol) of
Cy3 or Cy5 (GE Healthcare, Pittsburgh PA) according to the
manufacturer’s instructions. A pre-mixed aliquot of equal protein for
control and test samplewas labeled with 0.3 mL (120pmol) of internal
standard Cy2. A total of 5 mg protein from each H2O2 treatment was
Figure 8. Differential proteomic effects of hydrogen peroxide exposure upon SH-SY5Y cells and age-related protein alterations in
multiple species. A Multiple differential in-gel two-dimensional electrophoresis (DIGE) images of SH-SY5Y whole cell lysates treated with specific
concentrations (10 nM–10 mM) of hydrogen peroxide (Cy5-red) over seven days, compared to control cells (Cy3-green) receiving vehicle (PBS)
treatment. B depicts a coomassie-stained, two-dimensional gel of Cy5- or Cy3-labeled protein puncta, derived from SH-SY5Y cells exposed to 10 nM
peroxide or vehicle control for seven days. Arrows represent puncta that were subsequently excised for mass spectrometric identification. C Western
blot validation of proteins identified by tandem mass spectrometry of excised puncta. Whole-cell (w.c.) lysates from peroxide-treated (seven days) SH-
SY5Y cells were probed with the specific antisera denoted. D Normalized expression pattern of validated proteins from panel C in young (Y) or aged
(A) rat cortex. D1–D6 indicate expression of calreticulin, GIT2, GAPDH, calmodulin, lamin and 14-3-3 respectively. Panels E (E1–E6) and F (F1–F6) depict
analogous protein expression pattern investigation for the same proteins in young (Y) or aged (A) rhesus macaque or human cortex respectively.
Protein expression is quantified as actin-normalized arbitrary absorbance units (ABU).
doi:10.1371/journal.pone.0014352.g008
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internal standard, allowing for a total of 15 mg protein to be loaded
onto each gel. The solution was mixed with 125 mLo fr e h y d r a t i o n
buffer (7 M Urea; 4% CHAPS; 2 M thiourea; 1% carrier
ampholytes, pH 3–10, and 10 mM DTT) and incubated with a
7 cm immobiline dry strip, pH 3–10 NL (GEHealthcare). Gelswere
actively loaded at 50 V for 2 hrs using a Protean IEF cell (Bio-Rad)
before being subjected to isoelectric focusing as follows: 0–250 V
linear increase for 15 min; 250 V–500 V linear increase for 15 min;
500 V–1000 V rapid increase for 60 min; 1000 V–8000 V rapid
Table 4. Down-regulated proteins identified by MS/MS mass
spectrometry from DIGE gels following CMP treatment.
Identified Protein
Accession
number
Gene
Symbol
14-3-3 protein epsilon IPI00000816.1 YWHAE
14-3-3 protein eta IPI00216319.3 YWHAH
14-3-3 protein gamma IPI00220642.7 YWHAG
14-3-3 protein theta IPI00018146.1 YWHAQ
14-3-3 protein zeta/delta IPI00021263.3 YWHAZ
29 kDa protein (Tropomyosin 3) IPI00178083.2 TPM3
3-hydroxyisobutyrate dehydrogenase,
mitochondrial precursor
IPI00013860.3 HIBADH
Aldose reductase IPI00413641.7 ARM
Alpha-centractin IPI00029468.1 ARP1
Calmodulin IPI00075248.11 PHKD
Calreticulin precursor IPI00020599.1 CALR
Citrate synthase, mitochondrial precursor IPI00025366.4 CS
Elongation factor 1-beta IPI00178440.3 EEF1B2
Elongation factor 1-gamma IPI00000875.6 EEF1G
Gamma-enolase IPI00216171.3 ENO2
heterogeneous nuclear ribonucleoprotein D-like IPI00011274.2 HNRPDL
Isoform 1 of Calcyclin-binding protein IPI00395627.3 CACYBP
Isoform 1 of F-actin capping protein subunit beta IPI00026185.5 CAPPA3
Isoform 1 of Heterogeneous nuclear
ribonucleoprotein D
IPI00028888.1 HNRPD
Isoform 1 of L-lactate dehydrogenase A chain IPI00217966.7 LDHA
Isoform 1 of Tropomyosin alpha-4 chain IPI00010779.4 TPM4
Isoform 1 of Tropomyosin-1 alpha chain IPI00014581.1 TPM1
Alpha-enolase IPI00465248.5 ENO1
Isoform M1 of Pyruvate kinase isozymes M1/M2 IPI00220644.8 PKM1
Isoform M2 of Pyruvate kinase isozymes M1/M2 IPI00479186.5 PKM2
L-lactate dehydrogenase B chain IPI00219217.3 LDHB
Lung cancer oncogene 7 IPI00641950.3 GNB2L1
Pirin IPI00012575.1 PIRIN
Proliferation-associated protein 2G4 IPI00299000.5 PA2G4
Proteasome subunit alpha type 4 IPI00299155.5 PSMA4
Rab GDP dissociation inhibitor alpha IPI00010154.3 RABGDIA
Rab GDP dissociation inhibitor beta IPI00031461.1 RABGDIB
RcTPM3 (Fragment) IPI00377005.1 TPM3
Rho GDP-dissociation inhibitor 1 IPI00003815.3 ARHGDIA
T-complex protein 1 subunit delta IPI00302927.6 TCP1D
T-complex protein 1 subunit eta IPI00018465.1 TCPIE
tropomyosin 1 alpha chain isoform 2 IPI00000230.6 TPM1
U1 small nuclear ribonucleoprotein A IPI00012382.3 SNRP70
Voltage-dependent anion-selective
channel protein 1
IPI00216308.5 VDAC1
doi:10.1371/journal.pone.0014352.t004
Table 5. Up-regulated proteins identified by MS/MS mass
spectrometry from DIGE gels following CMP treatment.
Identified Protein
Accession
number
Gene
Symbol
Alpha-enolase IPI00013769.1 ENO1B
Beta-centractin IPI00029469.1 ARP1B
Bifunctional purine biosynthesis protein PURH IPI00289499.3 PURH
Cofilin-1 IPI00012011.6 CFL-1
Cytoplasmic dynein 1 light intermediate chain 2 IPI00011592.3 DNCH2
D-3-phosphoglycerate dehydrogenase IPI00011200.5 PHGDH
Glyceraldehyde-3-phosphate dehydrogenase IPI00219018.7 GAPDH
Heat-shock protein beta-1 IPI00025512.2 HSP70-1B
Heterogeneous nuclear ribonucleoprotein H IPI00013881.6 HNRPH1
HNRPA2B1 protein IPI00386854.5
HNRPA2B1
Inosine-59-monophosphate dehydrogenase 2 IPI00291510.3 IMPDH2
Isocitrate dehydrogenase [NADP], mitochondrial
precursor
IPI00011107.2 IDH1
Isoform 1 of Cytosol aminopeptidase IPI00419237.3 DNPEP
Isoform 1 of RuvB-like 1 IPI00021187.4 RUVBL1
Isoform 2 of ARF GTPase-activating protein GIT2 IPI00186690.6 GIT2
Isoform A of Lamin-A/C IPI00021405.3 LMNA
Isoform Long of Eukaryotic translation initiation
factor 4H
IPI00014263.1 EIF4H
Isoform Long of Glucose-6-phosphate 1-
dehydrogenase
IPI00216008.4 H6PD
Isoform Mitochondrial of Fumarate hydratase,
mitochondrial precursor
IPI00296053.3 FH
Isoform Short of Proteasome subunit alpha type 1 IPI00016832.1 PSMA1
paraspeckle protein 1 IPI00103525.1 PSP1
Peroxiredoxin-6 IPI00220301.5 PRDX6
Phosphoglycerate kinase 1 IPI00169383.3 PGK1
Platelet-activating factor acetylhydrolase IB
subunit gamma
IPI00014808.1
PAFAH1B3
Poly(rC)-binding protein 1 IPI00016610.2 PCBP1
poly(rC)-binding protein 2 isoform b IPI00012066.2 PCBP2
Pre-mRNA-processing factor 19 IPI00004968.1 PRP19
Proteasome subunit alpha type 6 IPI00029623.1 PSMA6
Protein disulfide-isomerase A3 precursor IPI00025252.1 PDIA3
RuvB-like 2 IPI00009104.7 RUVBL2
Septin-11 IPI00019376.6 SEPT11
Aldehyde dehydrogenase family 7 member A1 IPI00221234.5 ALDH7A1
Phosphoglycerate mutase 1 IPI00453476.2 PGAMB
Stress-induced-phosphoprotein 1 IPI00013894.1 STIP1
T-complex protein 1 subunit beta IPI00297779.7 TCP1B
Torsin A interacting protein 1 IPI00644766.2 TOR1AIP
Ubiquinol-cytochrome-c reductase complex core
protein 2, mitochondrial precursor
IPI00305383.1 UQCRC2
doi:10.1371/journal.pone.0014352.t005
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The strips were then reduced (1% DTT, Sigma) in equilibration
buffer (50 mM Bis-Tris, 6 M Urea, 30% glycerol, 2% SDS, pH 6.8)
for 15 min at room temperature followed by alkylation (2.5%
iodoacetamide, Sigma) in equilibration buffer for 15 min at room
temperature with constant agitation. Second dimension gels (4–12%
Bis-Tris acrylamide gels: Invitrogen Corporation) were separated at
80 V and scanned on a phosphorimager (Typhoon 9410, GE
Healthcare Systems).
Linear Ion-Trap Tandem Mass Spectrometry
Gel spots demonstrating consistent (reliable direction of
alteration, i.e. up or downregulated by $20%, n=6) differential
expression from DIGE staining were excised, incubated with
iodoacetamide and digested with sequence-grade trypsin (Promega
Corp., Madison WI) overnight at 37uC. After digestion, peptides
were extracted twice with extensive vortexing upon addition of
50/45/5 ACN/H2O/Formic Acid. Peptide digests were dried
with vacuum centrifugation, resuspended with 0.1% trifluoroacetic
acid and cleaned via C18 ziptips (Millipore, Billerica MA).
Peptides were then diluted with 2% ACN, 98% H2O, 0.1% formic
acid and loaded with a Surveyor (ThermoFinnigan, Waltham MA)
autosampler onto a 10 cm675 micron C18 column poured ‘in-
house’. Peptides were eluted with an ACN gradient delivered with
a Surveyor (ThermoFinnigan) HPLC at 300 nL/min from 2–40%
over 40 minutes. Eluting ions were analyzed using an LXQ ion
trap mass spectrometer (ThermoFinnigan) in a data-dependent
manner. The 3 most abundant ions from a full scan were selected
for fragmentation via collision-induced dissociation. Data was
extracted and searched using BioWorks software and the Sequest
algorithm (ThermoScientific) against an IPI human protein
database. Identified peptides were filtered using Xcorr cutoff
values of 2.5 and 3.0 for +2 and +3 charges. Resulting protein
identifications were further validated by matching theoretical mass
and pI (isoelectric point) values to their respective spots from the
two-dimensional gel.
Ligand Stimulation
Cells were serum-deprived overnight prior to ligand stimula-
tions with either: 10 nM dopamine, anandamide, lysophosphatidic
acid (LPA), histamine, b-methylcholine (all obtained from
Calbiochem, Gibbstown NJ) or 10 ng/mL brain derived neuro-
trophic factor (BDNF: Invitrogen, Carlsbad CA) for 0, 2, 5, 10, 30
and 60 minutes. Stimulation was terminated by aspiration of
culture media followed by one wash in ice-cold PBS and then
subsequent lysis in 80 mL of the previously mentioned NP-40-
based lysis buffer. Cells were scraped, agitated (40minutes, 4uC)
then clarified by centrifugation (140006g, 15minutes, 4uC).
Supernatant concentrations were determined by BCA assay,
normalized to 1 mg/mL, then processed for blotting as described
previously (Western Blotting).
Confocal Microscopy
Control or CMP SH-SY5Y cells were seeded in 8-well chamber
slides (Nunc Technologies, Rochester NY). For cell fixation, cells
were serum-deprived overnight, washed with PBS and fixed in ice
cold 100% methanol (10 minutes, 220uC). Monolayers were
washed with PBS and incubated in an NP-40-based permeabiliza-
tion buffer (PBS, 10% fetal calf serum, 1% bovine serum albumin,
0.2% Nonidet P-40, 30 minutes[153]). Fixed cells were then
blocked in PBS containing 10% fetal calf serum and 1% bovine
serum albumin (60 minutes, RT, agitation). Monolayers were then
incubated with 1:50 dilution of Alexafluor-568-phalloidin (Molec-
ular Probes) for 1 hour followed by a 1:1000 dilution of a-tubulin
(Sigma: 60 minutes, RT). Cells were then incubated with a 1:2000
dilution of fluoroscein isothiocynate-conjugated anti-mouse anti-
body for 1 hour at room temperature. Monolayers were washed
with PBS (365 min) between primary and secondary antibody
incubation. For mitochondrial staining slides were washed and
fixed as before, and incubated with 10 mM Mitotracker (Invitro-
gen, Carlsbad CA) for 20 minutes. Monolayers were washed with
PBS (365 min) before being visualized using an Olympus
Fluoview 3000 confocal microscope. To quantify alterations in
Mitotracker fluorescence, 100 microscopic fields were averaged for
their fluorescent intensity (Fuji Image Systems, ImageGauge v. 3.5)
and averaged between control and CMP conditions. Mitochon-
drial membrane potentials were also measured, in live cells, using
Table 6. Gene Ontology-biological process term analysis of
consistently-regulated proteins in CMP cells compared to
control.
GO-bp
Enrichment
R (O/E)
Probability
(p) Hybrid
Energy regulation
anaerobic glycolysis 100 1.16E-04 393.5542
tricarboxylic acid cycle
intermediate metabolism
50 8.63E-07 303.1995
pentose-phosphate shunt 66.67 4.13E-04 225.6146
tricarboxylic acid cycle 37.5 7.39E-05 154.9258
Neurophysiology
regulation of neuron differentiation 66.67 5.16E-04 219.1676
regulation of synaptic plasticity 50 6.29E-04 160.0675
neuron differentiation 7.14 3.11E-02 10.76169
Cellular signaling
regulation of GTPase activity 21.43 3.74E-04 73.44336
negative regulation of protein
kinase activity
16.67 6.82E-03 36.11081
Rho protein signal transduction 6.67 3.70E-02 9.550095
Translation regulation
translational elongation 25 2.82E-03 63.74377
mRNA catabolism 25 2.82E-03 63.74377
nucleotide metabolism 6.06 4.08E-03 14.4794
RNA processing 4.26 2.58E-03 11.0265
purine nucleotide biosynthesis 7.14 3.11E-02 10.76169
purine nucleotide metabolism 6.9 3.33E-02 10.19513
regulation of translation 6.25 4.17E-02 8.62415
Cell cycle
regulation of mitosis 12.5 1.05E-02 24.73513
regulation of progression through
cell cycle
3.77 4.66E-03 8.790185
Cell death
apoptosis 3.55 3.09E-03 8.910647
Protein metabolism
cytoskeleton organization and
biogenesis
3.88 8.80E-03 7.975407
organelle organization and
biogenesis
2.65 9.26E-03 5.388481
regulation of protein metabolism 3.8 4.38E-02 5.162398
protein folding 3.7 4.67E-02 4.923528
doi:10.1371/journal.pone.0014352.t006
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hodamine ethyl ester (TMRE: Invitrogen, Carlsbad CA).
Fluorescent Fluo-4 Imaging
Cells were seeded in a 35 mm glass-bottom culture dish
(MatTek Corporation, Ashland MA). Before dye-loading, cells
were serum-deprived overnight before equilibration in ACSF
(124 mM NaCl, 5 mM KCl, 1.25 mM NaH2PO4, 2 mM MgSO4,
10 mM glucose) and supplemented with 5 mM Fluo-4AM
(Invitrogen, Carlsbad CA: 20minutes, 37uC). Cells were then
washed three times with fresh ACSF and imaged. For each
experiment, either 100 mM CPA, 10 mM nifedipine, 1 mM v-
conotoxin or 50 mM glutamate was added to the cells at intervals
depicted in the relevant figures. Using digitization and quantifi-
cation (Fuji Image Systems Ltd.: L-Process and ImageGauge) of
multiple cells (n=10) from multiple microscopic fields (n$3) we
were able to generate relative intensity measurements for Fluo-4
fluorescent intensity (Arbitrary Units-Background/square pixels:
(AU-B/px
2)) for control or CMP cells. Measurement of calcium
levels was then performed as described previously [154].
Glucose Uptake Assay
SH-SY5Y cells, control or CMP-treated, were glucose- and
serum-deprived in Krebs Ringer buffer (25 mM NaCl, 5 mM
KCl, 1.25 mM NaH2PO4, 2 mM CaCl2, 1 mM MgCl2, 25 mM
NaHCO3)a t3 7 uC and 5% CO2 for 40 min on the day of
experimentation. To determine glucose uptake rates, 20 mM
glucose was added to the Krebs Ringer buffer and 30 mL aliquots
were taken at 0, 10, 15, 30, 60 and 120 min. Glucose
concentration from each aliquot was determined using a
fluorescent glucose assay kit (BioVision, # K606-100) as per
manufacturer’s instructions. Cells were lysed at the end of the
experiment and protein concentration was determined through a
BCA assay. Glucose uptake curves were then normalized for each
experiment against the respective total protein concentration
measured. To determine lactate production, cells were serum
starved for 40 minutes, in Krebs Ringer buffer, before being
exposed to 5 mM glucose for 4 hrs. The lactate produced and the
glucose taken up by the cells was measured using colorimetric
lactate (BioVision, # K627-100) and glucose (BioVision, # K606-
100) assay kits, per manufacturer’s instructions. Cells were lysed at
the end of the experiment and protein concentration was
determined through a BCA assay. The glucose uptake curve was
then normalized against the protein concentration.
Signaling Network Antibody Microarray
Preparation of protein samples, labeling, application to the
PanoramaH Cell Signaling Array chip and data analysis was
performed according to manufacturers’ instructions using the
proprietary solutions and equipment provided (PanoramaH Cell
Signaling Antibody Microarray, Sigma, St. Louis MO). Briefly,
cell lysates from control and H2O2 treatment batches were labeled
with Cy3 or Cy5 dye (GE Healthcare, Waltham MA) and the two
samples were applied simultaneously at equal protein concentra-
tions to the array. To ensure that comparisons of the two complex
samples of whole cell lysates were not confounded by gross
alterations in the proteome, we first assessed the global protein
expression using coomassie staining of the input samples as well as
specific antibody staining with anti-b-actin sera (data not shown).
The differential fluorescent signal intensity for each antibody spot
was then recorded with a phosphorimager (Typhoon 9410, GE
Healthcare). Each chip image was manually assessed for quality of
spot detection and quantitation by at least two independent
observers. Dye swapping (control or peroxide treated were labeled
in different experiments with either Cy3 or Cy5) was employed
and internal standards (bovine serum albumin, actin) were used to
Table 7. KEGG pathway analysis of consistently-regulated proteins in CMP cells compared to control.
KEGG pathway Enrichment R (O/E) Probability (p) Hybrid
Energy regulation
Glycolysis/Gluconeogenesis 67.189 3.73E-10 633.4793
Reductive carboxylate cycle (CO2 fixation) 120.482 1.22E-04 471.5228
Citrate cycle (TCA cycle) 73.349 9.29E-06 369.094
Metabolism/biosynthesis
Phenylalanine, tyrosine and tryptophan biosynthesis 109.89 1.47E-04 421.1739
Pyruvate metabolism 49.587 3.10E-05 223.5689
Cysteine metabolism 60.06 5.08E-04 197.8462
Cell cycle 29.779 7.33E-07 182.6947
Propanoate metabolism 41.322 1.08E-03 122.5858
Purine metabolism 38.6742
Pathophysiology
Huntington’s disease 52.91 6.58E-04 168.348
Pathogenic Escherichia coli infection - EPEC 30.722 1.95E-03 83.25556
Pathogenic Escherichia coli infection - EHEC 30.722 1.95E-03 83.25556
Antigen processing and presentation 18.365 5.36E-03 41.70502
Cell signaling
Insulin signaling pathway 10.1678 1.66E-02 18.09758
Wnt signaling pathway 9.241 1.99E-02 15.72217
Calcium signaling pathway 7.9618 2.26E-02 12.59317
doi:10.1371/journal.pone.0014352.t007
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antibody spot, fluorescent emission intensity was recorded across
the two primary, Cy3 (570 nm) or Cy5 (670 nm), emission
wavelengths. Ratios of the individual spot intensities (Cy-dye
independent as dye-sample swapping was performed) of CMP
compared to control samples were recorded (n=4). To consider
differential expression, the mean of the four spot ratios had to be
significantly different (greater or less than) to unity as well as the
internal controls (p,0.05, non-paired Student’s t-test). Only
significantly regulated spots/antibody identifications were consid-
ered for further analysis.
RNA extraction and Fluorometric Gene Array Analysis
RNA extraction and microarray analysis were carried out as
described previously [155]. RNA was isolated using the Qiagen
RNeasy Mini Kit (Qiagen, Inc. Valencia CA). RNA quality and
quantity was checked using an Agilent 2100 bio-analyzer and the
RNA 6000 nano-chips. Total RNA was used to generate biotin-
labeled cRNA using the Illumina TotalPrep RNA Amplification
Kit (Ambion; Austin, TX). A total of 0.75 mg of biotin-labeled
cRNA was hybridized at 58uC for 16 hours to Illumina’s Sentrix
MouseRef-8 Expression Bead-Chips (Illumina, San Diego, CA).
Arrays were then washed, blocked and labeled cRNA was detected
by staining with streptavidin-Cy3. Arrays were then scanned using
an Illumina BeadStation 5006Genetic Analysis Systems scanner
and the image data extracted using the Illumina BeadStudio
software, Version 3.0. All microarray data is MIAME compliant
and the raw data has been deposited in a MIAME compliant
database.
Bioinformatic analysis
Parametric analysis of datasets generated was conducted using
WebGestalt (http://bioinfo.vanderbilt.edu/webgestalt/). Analysis
was employed to identify the gene ontology (GO) term and KEGG
(Kyoto encyclopedia of genes and genomes) pathway groups that
most accurately represented the phenotypes of input datasets. We
employed the following parameters for the significant inclusion of
specific GO term and KEGG pathway groups, i.e. each group
needed a minimum population of two genes/proteins from the
input dataset and also possess a probability significance of
enrichment compared to a background dataset of less than 0.05
(hypergeometric test). The degree of enrichment (R: expressed as a
ratio) of each GO term/KEGG pathway was calculated as follows:
R=O/E where O is the observed protein/gene number in the
KEGG pathway/GO term cluster, E is the expected gene/protein
number in the KEGG pathway (Expected number of proteins in a
specific KEGG pathway for a specific experimental protein set =
Total number of proteins in the KEGG pathway for the reference
set x Total number of proteins in the experimental set/Total
number of proteins in the reference set). Using the Network
Explorer function in Ingenuity Pathway Analysis (IPA v8.5), the
most significantly populated gene networks for a specific geneset
were calculated based on the percentage population (by network
eligible focus molecules from input dataset), mediated by the gene
identities of the input datasets, of the resultant gene networks. A
comprehensive overview of the use of network algorithms and
significance generation is given in [156]. Genes were only
considered to be network eligible if they were known to interact
with at least one other molecule in the network. In each case more
than two genes were required to adequately populate a given
network with at least a probability (p) value of less than 0.05.
GeneIndexer (Computable Genomix LLC, Memphis TN), was
employed to indicate the degree of correlation of input
interrogation terms with significantly-regulated genes in a given
dataset. GeneIndexer generates correlation scores (0.1 minimal
cut-off to 1.0) for a specific gene in the geneset to the interrogation
term using a species-specific scientific abstract database containing
over one million human-curated entries. The basal transcriptional
dataset (CMP versus control) was interrogated with terms that
would potentially reveal a neurotrophin-based or age-related bias
in the CMP-mediated transcriptome set. To generate the
GeneIndexer matrix, only genes that were linked to at least two
interrogation terms were considered (Figure S4).
Electrophysiology
Whole-cell patch-clamp recordings were performed with an
Axopatch 200B (Axon Instruments, Union City, CA, USA)
amplifier at RT. SH-SY5Y cells were plated at a density of
15,000 per 15 mm round glass coverslip (Warner Instruments Inc.,
Hamden, CT). Coverslips containing cells were placed in a
recording chamber mounted on an inverted microscope
(BX51WI; Olympus, Tokyo, Japan). Cells were perfused with a
standard extracellular recording solution (in mM: NaCl 135, KCl
5, NaH2PO4 2, CaCl2 2, MgCl2 1, NaHCO3 25, D-Glucose 10,
pH 7.35, 300–315 mOsm). Patch pipettes were manufactured
from borosilicate capillary glass (G150F-4; Warner Instruments
Inc.) using a micropipette puller (P-97; Sutter Instruments,
Novato, CA, USA). Patch pipette resistance was 3–5 MV when
filled with intracellular recording solution (in mM: potassium
gluconate 120, NaCl 5, EGTA 0.1, HEPES 10, KCl 20, MgCl2 4,
phosphocreatine 10, magnesium-ATP 4, sodium-GTP 0.3,
pH 7.3, 290 mOsm). Whole-cell currents were recorded at
10 kHz and low-pass filtered at 2 kHz, using Pclamp 10 Software
(Axon Instruments). Recordings were transferred via a DAC
(Digidata 1440A; Axon Instruments) to a Dell PC and analyzed
offline with Clampfit 10 software (Axon Instruments). SHY-5Y
resting membrane properties were assessed during hyperpolarizing
10 mV steps. Resting membrane potentials were determined by
switching to I=0 mode, immediately following whole-cell
configuration. Unless indicated otherwise, cells were voltage
clamped at 240 mV with series and pipette capacitance
compensation.
Supporting Information
Figure S1 Chronic minimal peroxide treatment does not
significantly affect membrane electrophysiological properties. A
Current clamp family recordings from control- or CMP-treated
SH-SY5Y cells subjected to injection of steps from 20pA to
+100pA. B Steady-state current/voltage relationships gained in
voltage-clamp mode for control or CMP SH-SY5Y cells subjected
to voltage steps from 240 mV to +140 mV. C Classical cell
membrane parameters assessed for both control and CMP cells
included resting membrane potential (Vrest), input resistance
(Rinput), access resistance (Raccess) and membrane capacitance
(Cm).
Found at: doi:10.1371/journal.pone.0014352.s001 (0.84 MB TIF)
Figure S2 CMP affects multiple receptor systems with respect to
c-Src and extracellular signal-regulated kinase (ERK1/2) activa-
tion. A. Dopamine- (DA, 10 nM), histamine- (HA, 10 nM),
lysophospahtidic acid- (LPA, 10 nM) and anandamide- (ADA,
10 nM) mediated c-Src tyrosine-418 autophosphorylation in
control (blue bars) or CMP-treated (red bars) cells for the
respective times specified. B. Dopamine- (DA, 10 nM), histamine-
(HA, 10 nM), lysophospahtidic acid- (LPA, 10 nM) and ananda-
mide- (ADA, 10 nM) mediated ERK1/2 activation in control
(blue bars) or CMP-treated (red bars) cells for the respective times
specified. Statistical significance is indicated for changes in kinase
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vehicle-treated (control) cells. Statistical significance was measured
using a Student’s t-test (GraphPad Prism v.3): * - p,0.05; ** -
p,0.01.
Found at: doi:10.1371/journal.pone.0014352.s002 (1.81 MB TIF)
Figure S3 Textual correlation of multiple CMP-regulated
factors in SH-SY5Y cells. A. Heatmap representation of CMP-
significantly-regulated genes (gene symbol identities list on the left
of the heatmap) and their multiple correlation with various Latent
Semantic Indexing interrogation terms (Energy regulation, Ca2+
regulation, Glucose metabolism, Mitochondria, Aging, Oxidation,
Neurodegeneration, Stress). A red block indicates that the specific
gene correlates implicitly ($0.1 correlation score) with the
interrogation term and was upregulated in response to CMP,
while green indicates a downregulated implicitly correlated ($0.1
correlation score) gene. A black block represents a lack of
correlation between the specific gene and interrogation term.
Found at: doi:10.1371/journal.pone.0014352.s003 (1.57 MB TIF)
Figure S4 Venn diagram analysis of BDNF- or MeCh-induced
transcriptional regulation. A Venn diagram analysis of global
significantly-regulated genes with either 2, 4, or 8 hours of BDNF
stimulation (CMP-red circle, Control-blue circle). B Venn diagram
analysis of global significantly-regulated genes with either 2, 4, or
8 hours of MeCh stimulation (CMP-red circle, Control-blue
circle). Genes commonly regulated in control and CMP conditions
are indicated by black numbers.
Found at: doi:10.1371/journal.pone.0014352.s004 (2.36 MB TIF)
Figure S5 Response series-specific moduli of z ratio differences
between commonly CMP-Control regulated genes. A. Modulus
scores (independent of polarity of z ratio difference) for control
(CTRL) and CMP differences in z ratio after 2 hours of
stimulation with either MeCh or BDNF demonstrate a z ratio
difference. Similar series-specific z ratio difference modulus scores
for 4 (B) or 8 (C) hours of stimulation are depicted below. For both
BDNF or MeCh the gene regulation series are as follows: series
1=upregulated in CMP and control with z ratio CMP.CTRL;
series 2=upregulated in CMP/control with z ratio CTRL.CMP;
series 3=downregulated in CMP/control with z ratio
CMP,CTRL; series 4=downregulated in CMP/control with z
ratio CTRL,CMP. Values in each histogram are representations
of mean 6 SEM (n=3). Statistical significance was assessed using
a Student’s t-test. * p,0.05, ** p,0.01.
Found at: doi:10.1371/journal.pone.0014352.s005 (1.11 MB TIF)
Figure S6 Signal transduction network analysis of CMP-
regulated factors in SH-SY5Y cells. Using an un-biased signaling
network-generating algorithm (Ingenuity Pathway Analysis) the
most likely protein-protein interaction cluster was created from the
significantly altered signaling proteins in response to the CMP
protocol. The figure depicts the highest scoring functional
interaction network created from the CMP-controlled signaling
factors. Proteins denoted in capitalized text were directly derived
from the input protein set. A full description of the nature of
interactions based on the connecting lines can be found at the
following webpage linked to the IPA analysis module (https://analysis.
ingenuity.com/pa/info/help/help.htm#ipa_help.htm). Dashed lines
represent indirect protein interactions while solid lines represent
empirically measured direct interactions.
Found at: doi:10.1371/journal.pone.0014352.s006 (1.41 MB TIF)
Figure S7 Chromosomal loci distribution of CMP-regulated
gene products. A Human chromosomal location of genes
controlling expression of specific CMP-regulated proteins. The
panel depicts a schematic representation of the human chromo-
somal basepair (bp) gene loci (red + symbol) of proteins reliably
regulated by chronic minimal peroxide (CMP) treatment. B
histogram depicting the chromosomal frequency of genes
encoding CMP hydrogen peroxide-regulated proteins in SH-
SY5Y cells.
Found at: doi:10.1371/journal.pone.0014352.s007 (0.91 MB TIF)
Table S1 Significantly regulated basal-state genes induced by
implementation of the CMP paradigm in SH-SY5Y cells. Z ratios
for each specific gene represent the mean of three independent
analyzed cell lysates from CMP-treated cells compared to control-
treated (CTR) counterparts.
Found at: doi:10.1371/journal.pone.0014352.s008 (0.62 MB
DOC)
Table S2 Latent semantic indexing textual interrogation of basal
state CMP-dependent transcriptome alterations in SH-SY5Y cells.
Latent semantic indexing (LSI) correlation scores as well as
relevant gene symbols and genetic definition are denoted for each
specific underlined interrogation term. Genes identified using LSI
correlation that were upregulated compared to control by the
CMP protocol are denoted in bold while those downregulated
compared to control by CMP are denoted in italic.
Found at: doi:10.1371/journal.pone.0014352.s009 (0.44 MB
DOC)
Table S3 MeCh-significantly regulated genes after 2 hours of
stimulation in the control state SH-SY5Y cells. Each significantly
regulated gene is described via its accession number (ACCES-
SION), Gene Symbol (SYMBOL), Illumina array transcript
designation (TRANSCRIPT). For each gene the z-ratio of
expression compared to control vehicle-treated cells after 2 hours
of ligand stimulation is displayed (CTL MeCh 2).
Found at: doi:10.1371/journal.pone.0014352.s010 (0.94 MB
DOC)
Table S4 MeCh-significantly regulated genes after 4 hours of
stimulation in the control state SH-SY5Y cells. Each significantly
regulated gene is described via its accession number (ACCES-
SION), Gene Symbol (SYMBOL), Illumina array transcript
designation (TRANSCRIPT). For each gene the z-ratio of
expression compared to un-treated cells after 4 hours of ligand
stimulation is displayed (CTL MeCh 4).
Found at: doi:10.1371/journal.pone.0014352.s011 (1.26 MB
DOC)
Table S5 MeCh-significantly regulated genes after 8 hours of
stimulation in the control state SH-SY5Y cells. Each significantly
regulated gene is described via its accession number (ACCES-
SION), Gene Symbol (SYMBOL), Illumina array transcript
designation (TRANSCRIPT). For each gene the z-ratio of
expression compared to untreated cells after 8 hours of ligand
stimulation is displayed (CTL MeCh 8).
Found at: doi:10.1371/journal.pone.0014352.s012 (0.98 MB
DOC)
Table S6 MeCh-significantly regulated genes after 2 hours of
stimulation in the CMP state SH-SY5Y cells. Each significantly
regulated gene is described via its accession number (ACCES-
SION), Gene Symbol (SYMBOL), Illumina array transcript
designation (TRANSCRIPT). For each gene the z-ratio of
expression compared to untreated cells after 2 hours of ligand
stimulation is displayed (CMP MeCh 2).
Found at: doi:10.1371/journal.pone.0014352.s013 (1.03 MB
DOC)
Table S7 MeCh-significantly regulated genes after 4 hours of
stimulation in the CMP state SH-SY5Y cells. Each significantly
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SION), Gene Symbol (SYMBOL), Illumina array transcript
designation (TRANSCRIPT). For each gene the z-ratio of
expression compared to untreated cells after 4 hours of ligand
stimulation is displayed (CMP MeCh 4).
Found at: doi:10.1371/journal.pone.0014352.s014 (1.20 MB
DOC)
Table S8 MeCh-significantly regulated genes after 8 hours of
stimulation in the CMP state SH-SY5Y cells. Each significantly
regulated gene is described via its accession number (ACCES-
SION), Gene Symbol (SYMBOL), Illumina array transcript
designation (TRANSCRIPT). For each gene the z-ratio of
expression compared to untreated cells after 8 hours of ligand
stimulation is displayed (CMP MeCh 8).
Found at: doi:10.1371/journal.pone.0014352.s015 (0.99 MB
DOC)
Table S9 BDNF-significantly regulated genes after 2 hours of
stimulation in the control state SH-SY5Y cells. Each significantly
regulated gene is described via its accession number (ACCES-
SION), Gene Symbol (SYMBOL), Illumina array transcript
designation (TRANSCRIPT). For each gene the z-ratio of
expression compared to untreated cells after 2 hours of ligand
stimulation is displayed (CTL BDNF 2).
Found at: doi:10.1371/journal.pone.0014352.s016 (1.03 MB
DOC)
Table S10 BDNF-significantly regulated genes after 4 hours of
stimulation in the control state SH-SY5Y cells. Each significantly
regulated gene is described via its accession number (ACCES-
SION), Gene Symbol (SYMBOL), Illumina array transcript
designation (TRANSCRIPT). For each gene the z-ratio of
expression compared to untreated cells after 4 hours of ligand
stimulation is displayed (CTL BDNF 4).
Found at: doi:10.1371/journal.pone.0014352.s017 (1.23 MB
DOC)
Table S11 BDNF-significantly regulated genes after 8 hours of
stimulation in the control state SH-SY5Y cells. Each significantly
regulated gene is described via its accession number (ACCES-
SION), Gene Symbol (SYMBOL), Illumina array transcript
designation (TRANSCRIPT). For each gene the z-ratio of
expression compared to untreated cells after 8 hours of ligand
stimulation is displayed (CTL BDNF 8).
Found at: doi:10.1371/journal.pone.0014352.s018 (1.26 MB
DOC)
Table S12 BDNF-significantly regulated genes after 2 hours of
stimulation in the CMP state SH-SY5Y cells. Each significantly
regulated gene is described via its accession number (ACCES-
SION), Gene Symbol (SYMBOL), Illumina array transcript
designation (TRANSCRIPT). For each gene the z-ratio of
expression compared to untreated cells after 2 hours of ligand
stimulation is displayed (CMP BDNF 8).
Found at: doi:10.1371/journal.pone.0014352.s019 (0.94 MB
DOC)
Table S13 BDNF-significantly regulated genes after 4 hours of
stimulation in the CMP state SH-SY5Y cells. Each significantly
regulated gene is described via its accession number (ACCES-
SION), Gene Symbol (SYMBOL), Illumina array transcript
designation (TRANSCRIPT). For each gene the z-ratio of
expression compared to untreated cells after 4 hours of ligand
stimulation is displayed (CMP BDNF 4).
Found at: doi:10.1371/journal.pone.0014352.s020 (1.09 MB
DOC)
Table S14 BDNF-significantly regulated genes after 8 hours of
stimulation in the CMP state SH-SY5Y cells. Each significantly
regulated gene is described via its accession number (ACCES-
SION), Gene Symbol (SYMBOL), Illumina array transcript
designation (TRANSCRIPT). For each gene the z-ratio of
expression compared to untreated cells after 8 hours of ligand
stimulation is displayed (CMP BDNF 8).
Found at: doi:10.1371/journal.pone.0014352.s021 (1.15 MB
DOC)
Table S15 Common 2 hour MeCh-regulated gene series.
MeCh-regulated genes that were significantly elevated or reduced
compared to the respective unstimulated control cells in both the
control (untreated: MeCh-2h-Control vs. Control-Control) and
CMP state SH-SY5Y cells (MeCh-2h-CMP vs. Control-CMP).
The series number refers to the simplistic relationships between
the degree of regulation of the respective genes and the cellular
state (untreated or CMP). Series 1 (both upregulated) - MeCh-2h-
CMP vs. Control-CMP . MeCh-2h-Control vs. Control-Control;
Series 2 (both upregulated) - MeCh-2h-Control vs. Control-
Control . MeCh-2h-CMP vs. Control-CMP; Series 3 (both
downregulated) - MeCh-2h-Control vs. Control-Control .
MeCh-2h-CMP vs. Control-CMP; Series 4 (both downregulated)
- MeCh-2h-CMP vs. Control-CMP . MeCh-2h-Control vs.
Control-Control; Series 5 (downregulated in control, upregulated
in CMP); Series 6 (upregulated in control, down regulated in
CMP).
Found at: doi:10.1371/journal.pone.0014352.s022 (0.42 MB
DOC)
Table S16 Common 4 hour MeCh-regulated gene series.
MeCh-regulated genes that were significantly elevated or reduced
compared to the respective unstimulated control cells in both the
control (untreated: MeCh-4h-Control vs. Control-Control) and
CMP state SH-SY5Y cells (MeCh-4h-CMP vs. Control-CMP).
The series number refers to the simplistic relationships between
the degree of regulation of the respective genes and the cellular
state (untreated or CMP). Series 1 (both upregulated) - MeCh-4h-
CMP vs. Control-CMP . MeCh-4h-Control vs. Control-Control;
Series 2 (both upregulated) - MeCh-4h-Control vs. Control-
Control . MeCh-4h-CMP vs. Control-CMP; Series 3 (both
downregulated) - MeCh-4h-Control vs. Control-Control .
MeCh-4h-CMP vs. Control-CMP; Series 4 (both downregulated)
- MeCh-4h-CMP vs. Control-CMP . MeCh-4h-Control vs.
Control-Control; Series 5 (downregulated in control, upregulated
in CMP); Series 6 (upregulated in control, down regulated in
CMP).
Found at: doi:10.1371/journal.pone.0014352.s023 (0.57 MB
DOC)
Table S17 Common 8 hour MeCh-regulated gene series.
MeCh-regulated genes that were significantly elevated or reduced
compared to the respective unstimulated control cells in both the
control (untreated: MeCh-8h-Control vs. Control-Control) and
CMP state SH-SY5Y cells (MeCh-8h-CMP vs. Control-CMP).
The series number refers to the simplistic relationships between
the degree of regulation of the respective genes and the cellular
state (untreated or CMP). Series 1 (both upregulated) - MeCh-8h-
CMP vs. Control-CMP . MeCh-8h-Control vs. Control-Control;
Series 2 (both upregulated) - MeCh-8h-Control vs. Control-
Control . MeCh-8h-CMP vs. Control-CMP; Series 3 (both
downregulated) - MeCh-8h-Control vs. Control-Control .
MeCh-8h-CMP vs. Control-CMP; Series 4 (both downregulated)
- MeCh-8h-CMP vs. Control-CMP . MeCh-8h-Control vs.
Control-Control; Series 5 (downregulated in control, upregulated
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CMP).
Found at: doi:10.1371/journal.pone.0014352.s024 (0.57 MB
DOC)
Table S18 Common 2 hour BDNF-regulated gene series.
BDNF-regulated genes that were significantly elevated or reduced
compared to the respective unstimulated control cells in both the
control (untreated: BDNF-2h-Control vs. Control-Control) and
CMP state SH-SY5Y cells (BDNF-2h-CMP vs. Control-CMP).
The series number refers to the simplistic relationships between
the degree of regulation of the respective genes and the cellular
state (untreated or CMP). Series 1 (both upregulated) - BDNF-2h-
CMP vs. Control-CMP . BDNF-2h-Control vs. Control-Control;
Series 2 (both upregulated) - BDNF-2h-Control vs. Control-
Control . BDNF-2h-CMP vs. Control-CMP; Series 3 (both
downregulated) - BDNF-2h-Control vs. Control-Control .
BDNF-2h-CMP vs. Control-CMP; Series 4 (both downregulated)
- BDNF-2h-CMP vs. Control-CMP . BDNF-2h-Control vs.
Control-Control; Series 5 (downregulated in control, upregulated
in CMP); Series 6 (upregulated in control, down regulated in
CMP).
Found at: doi:10.1371/journal.pone.0014352.s025 (0.46 MB
DOC)
Table S19 Common 4 hour BDNF-regulated gene series.
BDNF-regulated genes that were significantly elevated or reduced
compared to the respective unstimulated control cells in both the
control (untreated: BDNF-4h-Control vs. Control-Control) and
CMP state SH-SY5Y cells (BDNF-4h-CMP vs. Control-CMP).
The series number refers to the simplistic relationships between
the degree of regulation of the respective genes and the cellular
state (untreated or CMP). Series 1 (both upregulated) - BDNF-4h-
CMP vs. Control-CMP . BDNF-4h-Control vs. Control-Control;
Series 2 (both upregulated) - BDNF-4h-Control vs. Control-
Control . BDNF-4h-CMP vs. Control-CMP; Series 3 (both
downregulated) - BDNF-4h-Control vs. Control-Control .
BDNF-4h-CMP vs. Control-CMP; Series 4 (both downregulated)
- BDNF-4h-CMP vs. Control-CMP . BDNF-4h-Control vs.
Control-Control; Series 5 (downregulated in control, upregulated
in CMP); Series 6 (upregulated in control, down regulated in
CMP).
Found at: doi:10.1371/journal.pone.0014352.s026 (0.46 MB
DOC)
Table S20 Common 8 hour BDNF-regulated gene series.
BDNF-regulated genes that were significantly elevated or reduced
compared to the respective unstimulated control cells in both the
control (untreated: BDNF-8h-Control vs. Control-Control) and
CMP state SH-SY5Y cells (BDNF-8h-CMP vs. Control-CMP).
The series number refers to the simplistic relationships between
the degree of regulation of the respective genes and the cellular
state (untreated or CMP). Series 1 (both upregulated) - BDNF-8h-
CMP vs. Control-CMP . BDNF-8h-Control vs. Control-Control;
Series 2 (both upregulated) - BDNF-8h-Control vs. Control-
Control . BDNF-8h-CMP vs. Control-CMP; Series 3 (both
downregulated) - BDNF-8h-Control vs. Control-Control .
BDNF-8h-CMP vs. Control-CMP; Series 4 (both downregulated)
- BDNF-8h-CMP vs. Control-CMP . BDNF-8h-Control vs.
Control-Control; Series 5 (downregulated in control, upregulated
in CMP); Series 6 (upregulated in control, down regulated in
CMP).
Found at: doi:10.1371/journal.pone.0014352.s027 (0.46 MB
DOC)
Table S21 Regulated proteins on Panorama cell signaling
antibody array following CMP treatment. The expression ratio
between that in CMP versus control (CTL) conditions was
measured from multiple (n=4) array experiments and is expressed
as a mean ratio with a calculated standard error of that meam
(SEM).
Found at: doi:10.1371/journal.pone.0014352.s028 (0.10 MB
DOC)
Table S22 Network analysis of antibody signaling array CMP-
significantly regulated proteins. Specific correlated networks were
generated using an un-biased algorithm using Ingenuity Pathway
Analysis (IPA). The highest network scores indicate the probabi-
listic likelihood of the specific protein network functionally
dominating the dataset. Pre-determined functional networks are
significantly populated with molecules (proteins) from the input
experimental dataset. The network score is a function of the
number and rarity of the specific experimental Focus molecules
that populate the specific network. Predicted functions are derived
from proprietary IPA software.
Found at: doi:10.1371/journal.pone.0014352.s029 (0.27 MB
DOC)
Acknowledgments
We would like to extend tremendous thanks to Dr. Marc Gleichmann, Dr.
Henriette van Praag, William H. Wood, Elin Lehrmann and Yongqing
Zhang for their help with this manuscript.
Author Contributions
Conceived and designed the experiments: SRM. Performed the experi-
ments: WC YZ SSP LW NM MDS BM SRM. Analyzed the data: WC YZ
SSP LW NM MDS BM SRM. Contributed reagents/materials/analysis
tools: YZ SSP LW NM MDS KGB BM SRM. Wrote the paper: WC
SRM.
References
1. Harman D (1956) Aging: a theory based on free radical and radiation
chemistry. J Gerontol 11: 298–300.
2. Barja G (2004) Free radicals and aging. Trends Neurosci 27: 595–600.
3. Loeb LA, Wallace DC, Martin GM (2005) The mitochondrial theory of aging
and its relationship to reactive oxygen species damage and somatic mtDNA
mutations. Proc Natl Acad Sci U S A 102: 18769–18770.
4. Warner HR (1994) Superoxide dismutase, aging, and degenerative disease.
Free Radic Biol Med 17: 249–258.
5. Bohr VA, Anson RM (1995) DNA damage, mutation and fine structure DNA
repair in aging. Mutat Res 338: 25–34.
6. Sohal RS, Weindruch R (1996) Oxidative stress, caloric restriction, and aging.
Science 273: 59–63.
7. Honda K, Casadesus G, Petersen RB, Perry G, Smith MA (2004) Oxidative
stress and redox-active iron in Alzheimer’s disease. Ann N Y Acad Sci 1012:
179–182.
8. JennerP (2003) Oxidativestress in Parkinson’sdisease.AnnNeurol 53:S26–S36.
9. Liochev SI, Fridovich I (2003) Mutant Cu, Zn superoxide dismutases and
familial amyotrophic lateral sclerosis: evaluation of oxidative hypotheses. Free
Radic Biol Med 34: 1383–1389.
10. Dhalla NS, Temsah RM, Netticadan T (2000) Role of oxidative stress in
cardiovascular diseases. J Hypertens 18: 655–673.
11. Rosca MG, Mustata TG, Kinter MT, Ozdemir AM, Kern TS, et al. (2005)
Glycation of mitochondrial proteins from diabetic rat kidney is associated with
excess superoxide formation. Am J Physiol. -Renal Physiol 289: F420–F430.
12. Valko M, Izakovic M, Mazur M, Rhodes CJ, Telser J (2004) Role of oxygen
radicals in DNA damage and cancer incidence. Mol Cell Biochem 266: 37–56.
13. Dumont P, Burton M, Chen QM, Gonos ES, Frippiat C, et al. (2000)
Induction of replicative senescence biomarkers by sublethal oxidative stresses in
normal human fibroblast. Free Radic Biol Med 28: 361–373.
14. Toussaint O, Remacle J, Dierick JF, Pascal T, Frippiat C, et al. (2002) From
the Hayflick mosaic to the mosaics of ageing. Role of stress-induced premature
senescence in human ageing. Int J Biochem Cell Biol 34: 1415–1429.
Neural Oxidative Adaptation
PLoS ONE | www.plosone.org 23 December 2010 | Volume 5 | Issue 12 | e1435215. Chen Q, Ames BN (1994) Senescence-like growth arrest induced by hydrogen
peroxide in human diploid fibroblast F65 cells. Proc Natl Acad Sci U S A 91:
4130–4134.
16. Gilca M, Stoian I, Atanasiu V, Virgolici B (2007) The oxidative hypothesis of
senescence. J Postgrad Med 53: 207–213.
17. Sto ¨ckl P, Zankl C, Hu ¨tter E, Unterluggauer H, Laun P, et al. (2007) Partial
uncoupling of oxidative phosphorylation induces premature senescence in
human fibroblasts and yeast mother cells. Free Radic Biol Med 43: 947–958.
18. Lin SS, Manchester JK, Gordon JI (2001) Enhanced gluconeogenesis and
increased energy storage as hallmarks of aging in Saccharomyces cerevisiae.
J Biol Chem 276: 36000–36007.
19. Picard B, Gagnie `re H, Geay Y, Hocquette JF, Robelin J (1995) Study of the
influence of age and weaning on the contractile and metabolic characteristics of
bovine muscle. Reprod Nutr Dev 35: 71–84.
20. Schulz TJ, Zarse K, Voigt A, Urban N, Birringer M, et al. (2007) Glucose
restriction extends Caenorhabditis elegans life span by inducing mitochondrial
respiration and increasing oxidative stress. Cell Metab 6: 280–293.
21. Brewer GJ (2009) Epigenetic oxidative redox shift (EORS) theory of aging
unifies the free radical and insulin signaling theories. Exp Gerontol 45:
173–179.
22. Linnane AW, Kios M, Vitetta L (2007) Healthy aging: regulation of the
metabolome by cellular redox modulation and pro-oxidant signaling systems:
the essential roles of superoxide anion and hydrogen peroxide. Biogerontology
8: 445–467.
23. Martin B, Mattson MP, Maudsley S (2006) Caloric restriction and intermittent
fasting: two potential diets for successful brain aging. Ageing Res Rev 5:
332–353.
24. Martin B, Golden E, Egan JM, Mattson MP, Maudsley S (2007) Reduced
energy intake: the secret to a long and healthy life? IBS J Sci 2: 35–39.
25. Brooks PJ, Cheng TF, Cooper L (2008) Do all the neurological diseases in
patients with DNA repair gene mutations result from the accumulation of DNA
damage? DNA Repair (Amst) 7: 834–848.
26. Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH (2010) Mechanisms
underlying inflammation in neurodegeneration. Cell 140: 918–934.
27. Fatokun AA, Stone TW, Smith RA (2008) Oxidative stress in neurodegener-
ation and available means of protection. Front Biosci 13: 3288–3311.
28. Stranahan AM, Zhou Y, Martin B, Maudsley S (2009) Pharmacomimetics of
exercise: novel approaches for hippocampally-targeted neuroprotective agents.
Curr Med Chem 16: 4668–4678.
29. Gooney M, Messaoudi E, Maher FO, Bramham CR, Lynch MA (2004)
BDNF-induced LTP in dentate gyrus is impaired with age: analysis of changes
in cell signaling events. Neurobiol Aging 25: 1323–1331.
30. Drapeau E, Nora Abrous D (2008) Stem cell review series: role of neurogenesis
in age-related memory disorders. Aging Cell 7: 569–589.
31. Mattson MP, Maudsley S, Martin B (2004) BDNF and 5-HT: a dynamic duo in
age-related neuronal plasticity and neurodegenerative disorders. Trends
Neurosci 27: 589–594.
32. Lommatzsch M, Zingler D, Schuhbaeck K, Schloetcke K, Zingler C, et al.
(2005) The impact of age, weight and gender on BDNF levels in human
platelets and plasma, Neurobiol Aging 26: 115–123.
33. Schaaf MJM, Workel JO, Lesscher HM, Vreugdenhil E, Oitzl MS, et al. (2001)
Correlation between hippocampal BDNF mRNA expression and memory
performance in senescent rats, Brain Res 915: 227–233.
34. Fumagalli F, Racagni G, Riva MA (2006) The expanding role of BDNF: a
therapeutic target for Alzheimer’s disease? Pharmacogenomics J 6: L 8–15.
35. Siegel GJ, Chauhan NB (2000) Neurotrophic factors in Alzheimer’s and
Parkinson’s disease brain. Brain Res Brain Res Rev 33: 199–227.
36. Cummings JL (2000) The role of cholinergic agents in the management of
behavioural disturbances in Alzheimer’s disease. Int J Neuropsychopharmacol
7: 21–29.
37. Meltzer CC, Smith G, DeKosky ST, Pollock BG, Mathis CA, et al. (1998)
Serotonin in aging, late-life depression, and Alzheimer’s disease: The emerging
role of functional imaging. Neuropsychopharmacology 18: 407–430.
38. Rollo CD (2009) Dopamine and aging: intersecting facets. Neurochem Res 34:
601–629.
39. Terao A, Steininger TL, Morairty SR, Kilduff TS (2004) Age-related changes
in histamine receptor mRNA levels in the mouse brain. Neurosci Lett 355:
81–84.
40. Loerch PM, Lu T, Dakin KA, Vann, JM, Isaacs A, et al. (2008) Evolution of
the aging brain transcriptome and synaptic regulation. PLoS ONE 3: e3339.
41. Johansson S (1994) Graded action potentials generated by differentiated human
neuroblastoma cells. Acta Physiol Scand 151: 331–341.
42. Furukawa K, Fu W, Li Y, Witke W, Kwiatkowski DJ, et al. (1997) The actin-
severing protein gelsolin modulates calcium channel and NMDA receptor
activities and vulnerability to excitotoxicity in hippocampal neurons. J Neurosci
17: 8178–8186.
43. Kim CH, Lisman JE (1999) A role of actin filament in synaptic transmission
and long-term potentiation. J Neurosci 19: 4314–4324.
44. Ferguson M, Mockett RJ, Shen Y, Orr WC, Sohal RS (2005) Age-associated
decline in mitochondrial respiration and electron transport in Drosophila
melanogaster. Biochem J 390: 501–511.
45. Lam PY, Yin F, Hamilton RT, Boveris A, Cadenas E (2009) Elevated neuronal
nitric oxide synthase expression during ageing and mitochondrial energy
production. Free Radic Res 43: 431–439.
46. Navarro A, Boveris A (2007) The mitochondrial energy transduction system
and the aging process. Am J Physiol Cell Physiol 292: 670–686.
47. Atamna H, Frey 2nd WH (2007) Mechanisms of mitochondrial dysfunction
and energy deficiency in Alzheimer’s disease. Mitochondrion 7: 297–310.
48. Boveris A, Navarro A (2008) Brain mitochondrial dysfunction in aging.
IUBMB Life 60: 308–314.
49. Fro ¨lich L, Blum-Degen D, Bernstein HG, Engelsberger S, Humrich J, et al.
(1998) Brain insulin and insulin receptors in aging and sporadic Alzheimer’s
disease. J Neural Transm 105: 423–438.
50. De Santi S, Leon MJ, Rusinek H, Convit A, Tarshish CY, et al. (2001)
Hippocampal formation glucose metabolism and volume losses in MCI and
AD. Neurobiol Aging 22: 529–539.
51. Borras C, Stvolinsky S, Lopez-Grueso R, Fedorova T, Gambini J, et al. (2009)
Low in vivo brain glucose consumption and high oxidative stress in accelerated
aging. FEBS Letts 583: 2287–2293.
52. Drzezga A, Lautenschlager N, Siebner H, Riemenschneider M, Willoch F,
et al. (2003) Cerebral metabolic changes accompanying conversion of mild
cognitive impairment into Alzheimer’s disease: a PET follow-up study.
Eur J Nucl Med Mol Imaging 30: 1104–1113.
53. Jagust WJ, Seab JP, Huesman RH, Valk PE, Mathis CA, et al. (1991)
Diminished glucose transport in Alzheimer’s disease: dynamic PET studies.
J Cereb Blood Flow Metab 11: 323–330.
54. Landfield PW (1987) Increased calcium-current’ hypothesis of brain aging.
Neurobiol Aging 8: 346–347.
55. Verkhratsky A, Shmigol A, Kirischuk S, Pronchuk N, Kostyuk P (1994) Age-
dependent changes in calcium currents and calcium homeostasis in mammalian
neurons. Ann NY Acad Sci 747: 365–381.
56. Viner TI, Williams TD, Scho ¨neich C (1999) Peroxynitrite modification of
protein thiols: oxidation, nitrosylation, and S-glutathiolation of functionally
important cysteine residue(s) in the sarcoplasmic reticulum Ca-ATPase.
Biochemistry 38: 12408–12415.
57. Toescu EC, Verkhratsky A, Landfield PW (2004) Ca
2+ regulation and gene
expression in normal brain aging. Trends Neurosci 27: 614–620.
58. Lopes GS, Ferreira AT, Oshiro ME, Vladimirova I, Jurkiewicz NH,
Jurkiewicz A, Smaili SS (2006) Aging-related changes of intracellular Ca
2+
stores and contractile response of intestinal smooth muscle. Exp Gerontol 41:
55–62.
59. Sharov VS, Dremina ES, Galeva NA, Williams TD, Scho ¨neich C (2006)
Quantitative mapping of oxidation-sensitive cysteine residues in SERCA in
vivo and in vitro by HPLC-electrospray-tandem MS: selective protein
oxidation during biological aging. Biochem J 394: 605–615.
60. Smaili SS, Rosenstock TR, Hsu Y-T (2008) Evaluation of Some Cell Death
Features by Real-Time, Real-Space Microscopy. Methods Enzymol 442:
27–50.
61. Puzianowska-Kuznicka M, Kuznicki J (2009) The ER and ageing II: Calcium
homeostasis. Ageing Res Reviews 8: 160–172.
62. Petit-Taboue MC, Landeau B, Desson JF, Desgranges B, Baron JC (1998)
Effects of healthy aging on the regional cerebral metabolic rate of glucose
assessed with statistical parametric mapping. NeuroImage 7: 176–184.
63. Biessels GJ, Kappelle LJ (2005) Increased risk of Alzheimer’s disease in Type II
diabetes: insulin resistance of the brain or insulin-induced amyloid pathology?
Biochem Soc Trans 33: 1041–1044.
64. Yap LP, Garcia JV, Han D, Cadenas E (2009) The energy–redox axis in aging
and age-related neurodegeneration. Adv Drug Deliv Rev 61: 1283–1298.
65. Sandebring A, Thomas KJ, Beilina A, van der Brug M, Cleland MM, et al.
(2009) Mitochondrial alterations in PINK1 deficient cells are influenced by
calcineurin-dependent dephosphorylation of dynamin-related protein 1. PLoS
One 4: e5701.
66. Cho DH, Nakamura T, Fang J, Cieplak P, Godzik A, et al. (2009) S-
nitrosylation of Drp1 mediates beta-amyloid-related mitochondrial fission and
neuronal injury. Science 324: 102–105.
67. McCampbell A, Truong D, Broom DC, Allchorne A, Gable K, et al. (2005)
Mutant SPTLC1 dominantly inhibits serine palmitoyltransferase activity in
vivo and confers an age-dependent neuropathy. Hum Mol Genet 14:
3507–3521.
68. Bras J, Singleton A, Cookson MR, Hardy J (2008) Emerging pathways in
genetic Parkinson’s disease: Potential role of ceramide metabolism in Lewy
body disease. FEBS J 275: 5767–5773.
69. Diener T, Neuhaus M, Koziel R, Micutkova L, Jansen-Du ¨rr P, et al. (2010)
Role of endonuclease G in senescence-associated cell death of human
endothelial cells. Exp Gerontol 45: 638–644.
70. Cho DH, Hong YM, Lee HJ, Woo HN, Pyo JO, et al. (2004) Induced
inhibition of ischemic/hypoxic injury by APIP, a novel Apaf-1-interacting
protein. J Biol Chem 279: 39942–39950.
71. Cho DH, Lee HJ, Kim HJ, Hong SH, Pyo JO, et al. (2007) Suppression of
hypoxic cell death by APIP-induced sustained activation of AKT and ERK1/2.
Oncogene 26: 2809–2814.
72. Schell MJ, Letcher AJ, Brearley CA, Biber J, Murer H, et al. (1999) PiUS (Pi
uptake stimulator) is an inositol hexakisphosphate kinase. FEBS Lett 461:
169–172.
73. Saiardi A, Erdjument-Bromage H, Snowman AM, Tempst P, Snyder SH
(1999) Synthesis of diphosphoinositol pentakisphosphate by a newly identified
family of higher inositol polyphosphate kinases. Curr Biol 9: 1323–1326.
Neural Oxidative Adaptation
PLoS ONE | www.plosone.org 24 December 2010 | Volume 5 | Issue 12 | e1435274. Kamimura J, Wakui K, Kadowaki H, Watanabe Y, Miyake K, et al. (2004)
The IHPK1 gene is disrupted at the 3p21.31 breakpoint of t(3;9) in a family
with type 2 diabetes mellitus. J Hum Genet 49: 360–365.
75. Illies C, Gromada J, Fiume R, Leibiger B, Yu J, et al. (2007) Requirement of
inositol pyrophosphates for full exocytotic capacity in pancreatic beta cells.
Science 318: 1299–1302.
76. Nomura Y, Okuma Y (1999) Age-related defects in lifespan and learning ability
in SAMP8 mice. Neurobiol Aging 20: 111–115.
77. Chen GH, Wang YJ, Wang XM, Zhou JN (2004) Accelerated senescence
prone mouse-8 shows early onset of deficits in spatial learning and memory in
the radial six-arm water maze. Physiol Behav 82: 883–890.
78. Butterfield DA, Poon HF (2005) The senescence-accelerated prone mouse
(SAMP8): a model of age-related cognitive decline with relevance to alterations
of gene expression and protein abnormalities in Alzheimer’s disease. Exp
Gerontol 40: 774–783.
79. Fujiwara M, Iwasaki K (1993) Toki-Shakayaku-San and Oren-Gedoku-To
improve the disruption of spatial cognition induced by cerebral ischemia and
central cholinergic dysfunction in rats. Physiother Res 7: 60–62.
80. Zheng Y, Cheng XR, Zhou WX, Zhang YX (2008) Gene expression patterns
of hippocampus and cerebral cortex of senescence-accelerated mouse treated
with Huang-Lian-Jie-Du decoction. Neurosci Lett 439: 119–124.
81. Uejima H, Mitsuya K, Kugoh H, Horikawa I, Oshimura M (1995) Normal
human chromosome 2 induces cellular senescence in the human cervical
carcinoma cell line SiHa. Genes Chromosomes Cancer 14: 120–127.
82. Uejima H, Shinohara T, Nakayama Y, Kugoh H, Oshimura M (1998)
Mapping a novel cellular-senescence gene to human chromosome 2q37 by
irradiation microcell-mediated chromosome transfer. Mol Carcinog 22: 34–45.
83. Apprey V, Afful J, Harrell JP, Taylor RE, Bonney GE (2005) Genes, age, and
alcoholism: analysis of GAW14 data. BMC Genet 6: S119.
84. Weinmann A, Galle PR, Teufel A (2005) LASS6, an additional member of the
longevity assurance gene family. Int J Mol Med 16: 905–910.
85. Yamashita S, Suzuki S, Nomoto T, Kondo Y, Wakazono K, et al. (2005)
Linkage and microarray analyses of susceptibility genes in ACI/Seg rats: a
model for prostate cancers in the aged. Cancer Res 65: 2610–2616.
86. North KE, Martin LJ, Dyer T, Comuzzie AG, Williams JT, et al. (2003) HDL
cholesterol in females in the Framingham Heart Study is linked to a region of
chromosome 2q. BMC Genet 4: S98.
87. Mukaetova-Ladinska EB, Milne J, Andras A, Abdel-All Z, Cerejeira J, et al.
(2008) Alpha- and gamma-synuclein proteins are present in cerebrospinal fluid
and are increased in aged subjects with neurodegenerative and vascular
changes. Dement Geriatr Cogn Disord 26: 32–42.
88. Valdez SR, Patterson SI, Ezquer ME, Torrecilla M, Lama MC, et al. (2007)
Acute sublethal global hypoxia induces transient increase of GAP-43
immunoreactivity in the striatum of neonatal rats. Synapse 61: 124–137.
89. Vanguilder HD, Yan H, Farley JA, Sonntag WE, Freeman WM (2010) Aging
alters the expression of neurotransmission-regulating proteins in the hippo-
campal synaptoproteome. J Neurochem 113: 157701588.
90. Takahashi K, Nakayama K, Nakayama K (2000) Mice lacking a CDK
inhibitor, p57Kip2, exhibit skeletal abnormalities and growth retardation.
J Biochem 127: 73–83.
91. Kim SY, Ryu SJ, Ahn HJ, Choi HR, Kang HT, et al. (2010) Senescence-
related functional nuclear barrier by down-regulation of nucleo-cytoplasmic
trafficking gene expression. Biochem Biophys Res Commun 391: 28–32.
92. Jee HJ, Kim HJ, Kim AJ, Bae YS, Bae SS, et al. (2009) UV light induces
premature senescence in Akt1-null mouse embryonic fibroblasts by increasing
intracellular levels of ROS. Biochem Biophys Res Commun 383: 358–362.
93. Inumaru J, Nagano O, Takahashi E, Ishimoto T, Nakamura S, et al. (2009)
Molecular mechanisms regulating dissociation of cell-cell junction of epithelial
cells by oxidative stress. Genes Cells 14: 703–716.
94. Kim JM, Lee EK, Park G, Kim MK, Yokozawa T, et al. (2010) Morin
modulates the oxidative stress-induced NF-kappaB pathway through its anti-
oxidant activity. Free Radic Res 44: 454–461.
95. Wu D, Gore AC (2010) Changes in androgen receptor, estrogen receptor
alpha, and sexual behavior with aging and testosterone in male rats. Horm
Behav 58: 306–316.
96. Enwere E, Shingo T, Gregg C, Fujikawa H, Ohta S, et al. (2004) Aging results
in reduced epidermal growth factor receptor signaling, diminished olfactory
neurogenesis, and deficits in fine olfactory discrimination. J Neurosci 24:
8354–8365.
97. Chamberlain JS, Metzger J, Reyes M, Townsend D, Faulkner JA (2007)
Dystrophin-deficient mdx mice display a reduced life span and are susceptible
to spontaneous rhabdomyosarcoma. FASEB J 21: 2195–2204.
98. Gannon J, Staunton L, O’Connell K, Doran P, Ohlendieck K (2008)
Phosphoproteomic analysis of aged skeletal muscle. Int J Mol Med 22: 33–42.
99. Dermietzel R, Traub O, Hwang TK, Beyer E, Bennett MV, et al. (1989)
Differential expression of three gap junction proteins in developing and mature
brain tissues. Proc Natl Acad Sci U S A 86: 10148–10152.
100. Kojima N, Shirao T (2007) Synaptic dysfunction and disruption of postsynaptic
drebrin-actin complex: a study of neurological disorders accompanied by
cognitive deficits. Neurosci Res 58: 1–5.
101. Erickson RR, Dunning LM, Holtzman JL (2006) The effect of aging on the
chaperone concentrations in the hepatic, endoplasmic reticulum of male rats:
the possible role of protein misfolding due to the loss of chaperones in the
decline in physiological function seen with age. J Gerontol A Biol Sci Med Sci
61: 435–443.
102. Zhou Q, Lam PY, Han D, Cadenas E (2008) c-Jun N-terminal kinase regulates
mitochondrial bioenergetics by modulating pyruvate dehydrogenase activity in
primary cortical neurons. J Neurochem 104: 325–335.
103. Bubber P, Haroutunian V, Fisch G, Blass JP, Gibson GE (2005) Mitochondrial
abnormalities in Alzheimer brain: mechanistic implications. Ann Neurol 57:
695–703.
104. Li B, Boast S, de Los SK, Schieren I, Quiroz M, et al. (2000) Mice deficient in
Abl are osteoporotic and have defects in osteoblast maturation. Nat Genet 24:
304–308.
105. Li B (2005) c-Abl in oxidative stress, aging and cancer. Cell Cycle 4: 246–248.
106. Yang S, Liu T, Li S, Zhang X, Ding Q, et al. (2008) Comparative proteomic
analysis of brains of naturally aging mice. Neuroscience 154: 1107–1120.
107. Levine AS, Gosnell BA, Morley JE (1986) Alterations in calmodulin levels in
tissues from aged animals. J Gerontol 41: 20–23.
108. Ishitani R, Kimura M, Sunaga K, Katsube N, Tanaka M, et al. (1996) An
antisense oligodeoxynucleotide to glyceraldehyde-3-phosphate dehydrogenase
blocks age-induced apoptosis of mature cerebrocortical neurons in culture.
J Pharmacol Exp Ther 278: 447–454.
109. Rodrı ´guez S, Eriksson M (2010) Evidence for the involvement of lamins in
aging. Curr Aging Sci 3: 81–89.
110. Miller JA, Oldham MC, Geschwind DH (2008) A systems level analysis of
transcriptional changes in Alzheimer’s disease and normal aging. J Neurosci 28:
1410–1420.
111. Majumdar AP, Tureaud J, Relan NK, Kessel A, Dutta S, et al. (1994)
Increased expression of pp60c-src in gastric mucosa of aged rats. J Gerontol 49:
B110–B116.
112. Matocha MF, Fitzpatrick SW, Atack JR, Rapoport SI (1990) pp60c-src kinase
expression in brain of adult rats in relation to age. Exp Gerontol 25: 47–54.
113. Li M, Mossman BT, Kolpa E, Timblin CR, Shukla A, et al. (2003) Age-related
differences in MAP kinase activity in VSMC in response to glucose or TNF-
alpha. J Cell Physiol 197: 418–425.
114. Kim HJ, Jung KJ, Yu BP, Cho CG, Chung HY (2002) Influence of aging and
calorie restriction on MAPKs activity in rat kidney. Exp Gerontol 37:
1041–1053.
115. Kilts JD, Akazawa T, Richardson MD, Kwatra MM (2002) Age increases
cardiac Galpha(i2) expression, resulting in enhanced coupling to G protein-
coupled receptors. J Biol Chem 277: 31257–31262.
116. Oudit GY, Kassiri Z, Patel MP, Chappell M, Butany J, et al. (2007)
Angiotensin II-mediated oxidative stress and inflammation mediate the age-
dependent cardiomyopathy in ACE2 null mice. Cardiovasc Res 75: 29–39.
117. Frillingos S, Tsolas O (1992) Age- and sex-related differences in the content of
prothymosin alpha in rat tissues. Experientia 48: 236–239.
118. Maric ´ D, Jankovic ´ BD, Veljic ´ J (1991) Immunostimulatory activity of
prothymosin-alpha in senescence. Ann N Y Acad Sci 621: 148–158.
119. Dosil M, Freire M, Go ´mez-Ma ´rquez J (1990) Tissue-specific and differential
expression of prothymosin alpha gene during rat development. FEBS Lett 269:
373–376.
120. Sarraj MA, McClive PJ, Szczepny A, Daggag H, Loveland KL, et al. (2007)
Expression of Wsb2 in the developing and adult mouse testis. Reproduction
133: 753–761.
121. Seshadri T, Uzman JA, Oshima J, Campisi J (1993) Identification of a
transcript that is down-regulated in senescent human fibroblasts. Cloning,
sequence analysis, and regulation of the human L7 ribosomal protein gene.
J Biol Chem 268: 18474–18480.
122. Taniguchi N, Carame ´s B, Ronfani L, Ulmer U, Komiya S, et al. (2009) Aging-
related loss of the chromatin protein HMGB2 in articular cartilage is linked to
reduced cellularity and osteoarthritis. Proc Natl Acad Sci U S A 106:
1181–1186.
123. Taniguchi N, Carame ´s B, Kawakami Y, Amendt BA, Komiya S, et al. (2009a)
Chromatin protein HMGB2 regulates articular cartilage surface maintenance
via beta-catenin pathway. Proc Natl Acad Sci U S A 106: 16817–16822.
124. Yan LJ, Thangthaeng N, Forster MJ (2008) Changes in dihydrolipoamide
dehydrogenase expression and activity during postnatal development and aging
in the rat brain. Mech Ageing Dev 129: 282–290.
125. Ip FC, Chung SS, Fu WY, Ip NY (2000) Developmental and tissue-specific
expression of DEAD box protein p72. Neuroreport 11: 457–462.
126. Zhu W, Lossie AC, Camper SA, Gumucio DL (1994) Chromosomal
localization of the transcription factor YY1 in the mouse and human.
Mammalian Genome 5: 234–236.
127. Adrian GS, Seto E, Fischbach KS, Rivera EV, Adrian EK, et al. (1996) YY1
and Sp1 transcription factors bind the human transferrin gene in an age-related
manner. J Gerontol A Biol Sci Med Sci 51: B66–75.
128. Wang X, Feng Y, Xu L, Chen Y, Zhang Y, et al. (2008) YY1 restrained cell
senescence through repressing the transcription of p16. Biochim Biophys Acta
1783: 1876–1883.
129. Rossner S, Sastre M, Bourne K, Lichtenthaler SF (2006) Transcriptional and
translational regulation of BACE1 expression–implications for Alzheimer’s
disease. Prog Neurobiol 79: 95–111.
130. Yaffe MB, Farr GW, Miklos D, Horwich AL, Sternlicht ML (1992) TCP1
complex is a molecular chaperone in tubulin biogenesis. Nature 358: 245–248.
131. Chiba T, Yao J, Higami Y, Shimokawa I, Hosokawa M, et al. (2007)
Identification of differentially expressed genes in senescence-accelerated mouse
Neural Oxidative Adaptation
PLoS ONE | www.plosone.org 25 December 2010 | Volume 5 | Issue 12 | e14352testes by suppression subtractive hybridization analysis. Mamm Genome 18:
105–112.
132. Okamoto S, Pouladi MA, Talantova M, Yao D, Xia P, et al. (2009) Balance
between synaptic versus extrasynaptic NMDA receptor activity influences
inclusions and neurotoxicity of mutant huntingtin. Nat Med 15: 1407–1413.
133. Sato Y, Yamanaka H, Toda T, Shinohara Y, Endo T (2005) Comparison of
hippocampal synaptosome proteins in young-adult and aged rats. Neurosci Lett
382: 22–26.
134. Nakamura K, Martin KC, Jackson JK, Beppu K, Woo CW, et al. (2006) Brain-
derived neurotrophic factor activation of TrkB induces vascular endothelial
growth factor expression via hypoxia-inducible factor-1alpha in neuroblastoma
cells. Cancer Res 66: 4249–4255.
135. Ogunshola OO, Antoniou X (2009) Contribution of hypoxia to Alzheimer’s
disease: is HIF-1alpha a mediator of neurodegeneration? Cell Mol Life Sci 66:
3555–3563.
136. Welford SM, Bedogni B, Gradin K, Poellinger L, Broome Powell M (2006)
HIF1alpha delays premature senescence through the activation of MIF. Genes
Dev 20: 3366–3371.
137. Xu K, Sun X, Eroku BO, Tsipis CP, Puchowicz MA, et al. (2010) Diet-induced
ketosis improves cognitive performance in aged rats. Adv Exp Med Biol 662:
71–75.
138. Wang D, Malo D, Hekimi S (2010) Elevated mitochondrial reactive oxygen
species generation affects the immune response via hypoxia-inducible factor-
1alpha in long-lived Mclk1+/- mouse mutants. J Immunol 184: 582–590.
139. Park SC, Park JS, Park WY, Cho KA, Ahn JS, et al. (2002) Down-regulation of
receptor-mediated endocytosis is responsible for senescence-associated hypo-
responsiveness. Ann N Y Acad Sci 959: 45–49.
140. Golden E, Emiliano A, Maudsley S, Windham BG, Carlson OD, et al. (2010)
Circulating Brain-Derived Neurotrophic Factor and Indices of Metabolic and
Cardiovascular Health: Data from the Baltimore Longitudinal Study of Aging.
PLoS One 5: e10099.
141. Li SC, Chicherio C, Nyberg L, von Oertzen T, Nagel IE, et al. (2009)
Ebbinghaus Revisited: Influences of the BDNF Val66Met Polymorphism on
Backward Serial Recall Are Modulated by Human Aging. J Cogn Neurosci 22:
2164–2173.
142. Silhol M, Arancibia S, Perrin D, Maurice T, Alliot J, et al. (2008) Effect of
aging on brain-derived neurotrophic factor, proBDNF, and their receptors in
the hippocampus of Lou/C rats. Rejuvenation Res 11: 1031–1040.
143. Ziegenhorn AA, Schulte-Herbru ¨ggen O, Danker-Hopfe H, Malbranc M,
Hartung HD, et al. (2007) Serum neurotrophins–a study on the time course
and influencing factors in a large old age sample. Neurobiol Aging 28:
1436–1445.
144. Quartu M, Lai ML, Del Fiacco M (1999) Neurotrophin-like immunoreactivity
in the human hippocampal formation. Brain Res Bull 48: 375–382.
145. Romanczyk TB, Weickert CS, Webster MJ, Herman MM, Akil M, et al. (2002)
Alterations in trkB mRNA in the human prefrontal cortex throughout the
lifespan. Eur J Neurosci 15: 269–280.
146. Tapia-Arancibia L, Aliaga E, Silhol M, Arancibia S (2008) New insights into
brain BDNF function in normal aging and Alzheimer disease. Brain Res Rev
59: 201–220.
147. Tong L, Balazs R, Thornton PL, Cotman CW (2004) Beta-amyloid peptide at
sublethal concentrations downregulates brain-derived neurotrophic factor
functions in cultured cortical neurons. J Neurosci 24: 6799–809.
148. Murer MG, Boissiere F, Yan Q, Hunot S, Villares J, et al. (1999) An
immunohistochemical study of the distribution of brain-derived neurotrophic
factor in the adult human brain, with particular reference to Alzheimer’s
disease. Neuroscience 88: 1015–1032.
149. McEwen BS, Wingfield JC (2003) The concept of allostasis in biology and
biomedicine. Horm Behav 43: 2–15.
150. Martin B, Pearson M, Kebejian L, Golden E, Keselman A, et al. (2007) Sex-
dependent metabolic, neuroendocrine, and cognitive responses to dietary
energy restriction and excess. Endocrinology 148: 4318–4333.
151. Maudsley S, Pierece KL, Zamah AM, Miller WE, Ahn S, et al. (2000) The
beta(2)-adrenergic receptor mediates extracellular signal-regulated kinase
activation via assembly of a multi-receptor complex with the epidermal growth
factor receptor. J Biol Chem 275: 9572–9580.
152. Davidson L, Pawson AJ, Lo ´pez de Maturana R, Freestone SH, Barran P, et al.
(2004) Gonadotropin-releasing hormone-induced activation of diacylglycerol
kinase-zeta and its association with active c-Src. J Biol Chem 279:
11906–11916.
153. Davidson L, Pawson AJ, Millar RP, Maudsley S (2004a) Cytoskeletal
reorganization dependence of signaling by the gonadotropin-releasing
hormone receptor. J Biol Chem 279: 1980–1993.
154. Sheehan JP, Swerdlow RH, Miller SW, Davis RE, Parks JK, et al. (1997)
Calcium homeostasis and reactive oxygen species production in cells
transformed by mitochondria from individuals with sporadic Alzheimer’s
disease. J Neurosci 17: 4612–622.
155. Martin B, Pearson M, Brenneman R, Golden E, Wood W, et al. (2009)
Gonadal transcriptome alterations in response to dietary energy intake: sensing
the reproductive environment. PLoS One 4: e4146.
156. Calvano SE, Xiao W, Richards DR, Felciano RM, Baker HV, et al. (2005) A
network-based analysis of systemic inflammation in humans. Nature 437:
1032–1037.
Neural Oxidative Adaptation
PLoS ONE | www.plosone.org 26 December 2010 | Volume 5 | Issue 12 | e14352